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ABSTRACT

Althoush a large amount of work has been reported in the
literature on the effeets of insulin

Oft

protein biosynthesis.

very little attention has b.en paid to the corresponding effects
of the oral hypoglycemic agents.

Since these compounds are

widely used in the control of certain types of diabet.s. it w.s
considered worthwhile to investiaate their effect on protein
biosynthesis. and incidentally. to evaluate their efficacy in
the control of the entire diabetic state.
The measurement of protein synthe.is used was t:he incorpor-

ation of leucine-C14 into hepatic protein. using a rat liver
micro.omal system.

The.Hl

n~Ei

addition of any of three agents

(tolbutamide. chlorpropamide, or phenethylbiguanide) was Observed
to inhibit the incorporation of leucine.C 14 into the protein of
normal rat liver.

This inhibition was in all ca.e. directly

proportional to the _ount of asent added. over the range inve.tigated.

When the liver microsome. from alloxan-diabetic

animals were employed. the control incorporation was so low that
it was difficult to observe an inhibition.
Other experiments on this

J.a nIt' effect of the oral hypo-

glycemic agents demonstrated that it was observed when the
isotope. lysine-C14 and phenylalanine.c 14 ware employed in place
of leucine-C 14.

It was further noted that the incorporation of

the isotope into both soluble and microsomal bound protein was
ii

~---------------------------~~----------------------------~

inhibited by the compounds to the same extent.
Studies on the in

~t[O

site of aetion indicate that botb

tolbutamide and phenethylbiguanide inhibit protein synthesis
somewhere at the microsomal level, but not at the final step
where the protein is released from the ribosome.
Other experimen.ts were performed in which animals were injected with the agents and the ability of their livers to incorporate leucine-C14 into protein in vit;[o was compared with that
of control

an~ls

injected with an equtmolar amount of aaline.

A significant decrease in the ability of an antmal's liver
microsome. to incorporate the isotope into protein was observed
following the injection of 0.35 m moles tolbutamide or 0.10 m
moles phenethylbi&uanide.

The continued daily injection (for a

period of four to 8iSht days) of amaller amounts of either agent
were without siin1ficant .ftect.
These results are exactly opposite those reported for insulin.

Whereas tolbutamide and

phen.thylbl~uanid.

tein synthesis in vitro, insulin acceleratea it.

inhibit pro-

This 8U8&eats

that the oral hypoglycemic _sent. studied, although very proficient at lowering blood a,luco •• t do not possess all the other
attributes of insulin.

They cannot, of themselves, aid the

negative protein balanee associated with diabetes; they may. in
faet, due to their inhibitory effeets. agaravat. the condition.
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HECHAN SM

.Qf. PROTEIN rnOSYNTHESIS

The classical scheme for the biosynthesis of protein by
the living cell might be described by a .erie. of five steps.

1.

Activation
A.A. + ATP +

II.

Ill.

Enz.

--~.

Enz-ANP-A.A.

Transfer of A.A. to s-RNA

Attraction of Various Amino Acids to Ribosomal
Template
s-RNA-~\A

+ "Ribosomal RNA Template U

1

Ribosomal RNA --- (s-RNA-AA)n
IV.

roanation of Peptide Bonds
n(s-RNA-AA) -......,. (A.A)n +

V.

It

.-RNA

aelea.e of the Ribosomal Bound Protein into the
cytoplasmic sap.

This scheme represents one method of visualizing the process
but is not intended to be taken .s literally true.

Recent

evidence has sreatly elaboratad upon it and consequently modified it to a considerable extent.

For example, it is highly

doubtful that steps IV and V occur independently of each other,
but there is no reason why we cannot think of them in that way
in order to better visualize the process.

With this general

mechanism in mind, then, let us investigate the process in more

__
00 _ _ _ _ _ _ _~_.rll'
.._

....
l
..............................
a
_

......................._ _ _
011. _ _
~_!

__
, __

-2detail.
Ac;tivation of the Amino Acids
The use of radioactive amino acids containing the isotope
carbon-14. had been generally used about 1945-50 to demonstrate
that living cells can take up amino aeids from thei.r nutrient
medium and build these into proteins.

Ruptured eells, pre-

viously disintegrated under certain mild conditions. retained
this ability (119).

It soon became obvious to the investigators

that such cell-free systems were dependent upon a supply of
ATP.

Thus inhibitors of ATP formation in cell mitoehondria

sueh .s anerobiosis, ars.nite. and 2.4-dinitrophenol prevented
the uptake of amino acids into protein in many systems (10).
This absolute requirement for ATP has been verified in hundreds of laboratories using isolated mierosome. and cell sap
for the incorporating system.
The ATP requirement described strongly suggested that the
activation of amino acids required a reaction with this substanc.
The first proof. of this postulate came in 1955 involving
systems in supernatant fractions fram animal tissues (39) and
microbial cells (24).

Both of these reports described an ex-

ehange reaction between labeled inorganic pyrophosphate (pp32)
and ATP which required the participation of amino acids.

The

follOwing equilibrium reaction was suggested:
AA + ATp 32 ,
....), AA-AMP + pp32
~----------------------------------"------------------------------~

,. . . .__________. . . . .

...,_.__...."'. . . .___
1

--=-~---'

_ _ _ !S!O~'?>'~~' _

_. . ,

It was further observed (39) that adding a large excess of one
amino acid does not prevent an additional pp32.exChange upon
the addition of another amino acid.

This early observation

indicated that each amino acid has its own corresponding
activating enzyme so that no competition exists for binding
site ••
Direct evidence for the role of ATP in forming an activated
amino acid adenylate complex was demonstrated in 1958 by
Karasek .IS. !!. (46) and by Kingdon .t.I .!.! (48).

These workers

isolated large amounts of purified tryptophane activating enzyme
(15 - 50 ag) and used this to form the corresponding adenylate,
one molecule per molecule of enzyme.

The product was rel.sed

by denaturation of the enzyme with acid and was shown to be
identical with synthetic tryptophane adenylate in chromatographic
and electrophoretic behavior, .s well as in cas. of breakdown
by hydroxylamine and water.

The structure of an amino acid

adenylate (AA-AMP) is given in Fisure 1.
The enzyme. required for the activation have been studied
in some detail.

ATP is the only nucleoside triphosphate used

for the activation of the amino acids, so the binding sites must
be specific for the purine base adenine (39).

MagneSium ions

are necessary for activity, but their function remains obscure;
in some systems pota.sium ion is also required (4).

Chemicals

which react with free sulfhydryl group., such a. p-chloromercuribenzoate, can cauae 108s of activity (20).

It is interesting to

..........----------------------------------,----------------------~
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R varies with the Amino Acid

Figure I
An Amino Acid Adenylate
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note that these enzymes are not absolutely specific.
the isoleucine-activating enzyme from

~-Col~

For example,

can a180 cause the

activation of valine, a1t:hough at: a slower rate (7).

Con-

versely, valine activation by the valine-activating enzyme 1s
inhibited by isoleucine (63).

Obviously, the ability of

E-~2ti

to incorporate a specific amino acid lnto a giverl protein does
not: reside solely in the speciflcity of the activating enzyme.

A;;asmmt o( MiDo Agid, ;2 '-W
The amino acidad.nylat ....nzym. complex reacts with a
lpacific s-RNA molecule to form the amino acyl-s-RNA complex.
The activating enzyme 1s liberated to be used again and AMP is
also formed.

For each amino acid there app.ars to be at l •• st

one .pecific a-RNA molecule pre.ent.

The amino acid 1s attached

by it. carboxyl group, forming an ••ter linkage to either the
2' or the 3' hydroxyl group of the ribo.e in the terminal
adeno.ine group of the .-RNA molecrule (95).
which form, 21 or 3', 'the

amino~cyl

It is not clear in

a-RNA is first made or in

whicb form it is utill.zed; and, 1.n fact, the qu••tion may be
meani1l81•••• ince r.cent work. bAs .hown that the amlno acyl
group l.In:erchang•• rapidly between th•• e two posslble positlona
(75) •

In the pr.senc. of ATP and an exee •• of activating enzyme,
a preparation of unfraetionated .-RNA may be saturated to a
definlte level with lncr... lng amounts of an amino acid.

Fur-

~-------------------------------,~~-------,----------------------~

ther additions of this amino acid do not increase the amount of
label attached to the a-RNA.

On the other '-1&nd, if now a

second amino acid 1s added, it will be taken up and attaChed to
its specific a-RNA moleeule. in the preparation (5).
The proof that the amino acid i. covalently bonded to tbe

s-RJ."1A has been provided by the action of panereatie ribonuclea.se
upon a radioactively labeled amino acyl-saRNA.

Thts enzyme

det;rades the s-RNA with the liberation of the terminal adenosine
moiety to which the radioactive amino acid is .till attaehed.
This amino acyl-adenosine compound was isolated by electrophoresis and chromatography and compared with the synthetic ea.-

pound.

Its structure vas further verified by degradation to

adenosine and the amino acld (118).
StEYs¥yre 2f s-RNA
Normal preparations of s-RNA from miera-organisms or from
mammalian liver have a number of eharaeteristies in cOt'lb'non (109).
All have approximately the

.am~

molecular weight (about 25,000)

corre.ponding to a total of 75 - 80 nucleotides.

These are

arranged in a single chain at one end of which i8 a fre. 51
phosphate group attached to a terminal guanylic acid residue.
The other end of the chain (the site of attachment of the
amino aeid) invariable terminate. in the .equenee cytosinecytosine-adenine.

It i8 believed that the nucleotide sequence

in the interior of the chain varie. with the different amino

acid-specific: a-RNA molecules.

In solution a-RNA shows hyperchromicity (an increase in
absorba.nce upon heating) '-Ihich supports the idea of c:ons:lderable base pairing in the molecule (96).

chromicity on
has been

heatin~

Because this hyper-

i8 completely and rapidly reversible. it

assumed that the native molecule is fonned from a

single nucleotide chain bent back upon ltself. leaving one or
more loops in the structure.

Poasibly 1t 1s the looped part of

the molecule with exposed nueleotide bases which recognizes the

nueleotide sequence of the m-RNA when the a-RNA aligns itself
on the template.

Canton! (15) postulated that it is this loop

in the structure of the a-RNA molecule that contains the base
sequence complementary to the eo(U.n& triplet of the m-RNA; he
has called this the Noo22. because lt is complementary to the
!(OPON. the current name for the coc:U.ng unit.
There are theoretlcally four speclal altes on the s-RNA

molecule Whlch might be discus.ed.
1.

AMINO ACID ATTACfD(DlT 6,i:fi.

This i8 found at one end

of the chain bearing the ter,minal sequence cytosine.
cytosine-adenine and appears to be the 8ame for all types
of a-RNA.

2.

ACTIVATING ENZl)tE RECOGNITION SITE.

There must be a

site which recognize. the specific amino acid activating
eftz,.e so that only the proper amino acid would be bound
by an individual s-RNA..

In other words. there must be a

h -_______________________________,________________________________~

-8site on the leucine specific a-RNA which would attract
only the ENZ-AMP-Leu complex.

The location on the mole-

cule of auch a site is st111 obscure.
3.

CODING RECOGNITION SITE.

This is the so called

Nonce

which is specific for one type of a-RNA and hence specific
for one particular amino acid.

Thia site is responsible

for recognizing the triplet code on the template thereby
arranging the individual amino acids into their proper
order.

It is likely that this site is found at the loop

of the s-RNA structure where the bases are exposed (not
paired).
4.

RI80SOME BINDING SITE.

It might be necessary for the

s-RNA molecule to bind to the ribosome to ensure a
.ufficiently long time of positioning of the amino acyla-RNA on the template.

The existence of this last site is

open to question since the attachment of the a-RNA to the
template may be 'simply by base pairing of the NODOC with
the CODON.
It is believed that the nucleotide sequence of the a-RNA
molecule is formed by the DNA-dependent enzyme, RNA polymerase,
which transcribes some portion of the DNA molecule in the
nucleus (98).

This enzyme probably synthesizes the entire s-RNA

molecule with the exception of the invarient cytosine-cytosineadenine terminal residues.

These have been shown to be added

to the molecule by a separate enzyme isolated from the 100,000

-9-

& supernatant (6).

It appears .s though the RNA polymerase makes

a nucleotide chain without the last three nucleotide. and that

these are then attached in their correct sequence by the tel'·
minal-adding enzyme using C'f? and ATP.
To clarify this procedure, it mig,nt be well to review
briefly some nucleic acid biochemistry.
bas~es:

DNA

consists of four

adenine, guanine. cytosine, and thymine.

RI'1A contains

the first three base., but uracil i8 substituted for thymine in
all eases.

The bases are complementary to each other, so that

adenine will be attracted to uracil (or thymine) while guanine
will be attraeted to cytosine.

The basis for such attract10ns

is the formation of hydrogen bonds between the moleculea (109).
Hence the following relationships exist.

DNA

m-RNA
s-RNA

A

- G - C - A - A - T

U - C - G - U

- U

-

A

t-G_-J\-~-J
a-RNA

a-aNA

DNA having the partial sequence described will form m-RUA
which is complementary tu it as illustrated in the d1ae,ram.
Each triplet of Bas/!}s in the m-RNA will, in turn, attract an
.-R~\

it.

molecule having 3 fre. bases which are complementary eo
Thus the indiy1.dul!I..l amino acids (which. are attached to the

s-RNA) are lined up tn their proper sequence.

§TRUCTUnB OF RXBOSONES

-10removal of larger particles. by precipitation at pH 5 and
chromatography on ion exchange columns.

In i-Galt t the ribo-

somes contain 60 per cent protein by weight and 40 per cent

RNA; their stability was found to be dependent on the magnesium
ion concentration (107).

A number of ribosomal subunits were

discovered in E-Coli, differing greatly in molecular weight
(and hence in their sedimentation constants).

In a fairly high

magnesium concentration (1 mM) 70S and 100S ribosomes are .een
6

with molecular weights of 2.8 and 5.9 x 10 ,respectively.
tbe magne.ium concentration 1s lowered to 0.1

aM

If

however, these

ribosomes disaggregate forming a mixture of 30s and 50S ribosome. with molecular weights 0.85 and 1.8 x 106 respectively.
This disaggregation 1s reversible, and if the magnesium ion
concentration is restored to 1 aM, the higher moleeular weight
ribosomes (70S and 100S) are again evidenced.
The structure of these ribosomal particles bas not been
elucidated much beyond this point.

As yet no definite function

bas been established for either the ribosomal RNA or the ribosomal protein, other than simply a .tructural one.

CODING SP:;;CIFICITY OF s-RlY\
In 1961 an experiment was performed which demonstrated that

the a-RNA from one species may be used to synthesize a protein
typical of a different species (104).

Purified ribosomes and

polysomes were isolated from the retieulocytes of rabbits.

~--------------------------------------------------------------~

~------------------------------------------'--------------------

-11These, presumably containing the m-RNA for rabbit hemoglobin
were incubated with charged s-RNA from E-Coli.

This amino aeyl.

a-RNA from i-CpU. contained all the amino acids required for

the synthesis of hemoglobin of Which only leucine was radioactive with C14 •

It was discovered that the radioactivity was

incorporated into soluble rabbit hemoglobin in this system.
radioactive nm4ly-synthesized hemoglobin

~~s

The

shown to be the

same as normal rabbit hemoglobin by means of tryptic digestion
followed by "tin.serprinting" ot the resultant peptides.
This expertment proved that, in the presence of rabbit
m-RNA in ribosome. and polysom.. and ot

i-~9li

a-RNA, the amino

acids were inserted into their correct positions in the peptide
chain.

Henee it was deduoed that the information for making

the protein was to be found in the polysome fraction rather than
in the a-RNA.
Another insenious experiment has demonstrated that the
placement of a given amino acid on the template is directed by
the specificity of the a-RNA and not by the amino acid itaelf

(17).

In this ea.e, § ... Cgll a-RNA was charged with cysteine-C l4 •

At this point. the cysteine-Cl4 is linked with the a-RNA
specifie for cysteine.

By ehemical reduction with Raney nickel.

the cysteine was converted to alanine td thout breaking the
linkage between the amino aeid and the a-RNA.

Using a cell-free

system, it was demonstrated that this alanine-C I4 was incorporated into protein by synthetic polyribonucleotides that contained
~------------------------------------.-,----------------------------~

-12the triplets necessary for cysteine incorporation.

Furthermore,

the alanyl_C14.s.RNAcy's. was not incorporated into protein by
polyribonucleotidel that did have the coding properties for
alanine.

In short, the amino acid goes where the s-RNA directs.

tliSSENGER - RNA FORMATION
The first hint of the existence of a me •• anser RNA - a
template for protein synthesis distinct from the bulk RNA of
the Ribosomes - is found in an observation by Hershey (38).
After a bacterium was infected by a phage, net RNA Iynthesis
ceased, but a small RNA fraction was seen to turn over rapidly.
Shortly after this. Volkin and Astrachon (103) showed that once
a bacterium is infected with a bacteriophage, the syntheSis of
normal bacterial RNA and proteins ceases, but that after a
short lag period, the syntheSiS of bacteriophage ... specific
proteins begins.

During the lag period some

Rt~

is rapidly

synthesized with a base composition similar to the phage DNA
but totally unlike the bacterial DNA.

This 1s presumedly the

new messenger RNA directed by the DNA of the infecting bacteriophage and required for the synthesis of the bacteriophage
proteins.
A clear demonstration of the formation of messenger RNA
was performed by Brenner, Jacob, and Me.elson (12).

Bacteria

were grown in a medium containing the heavy isotopes of carbon
and nitro&en (ie. ell and N1S).

At the time of infection of

-13-

the bacteria with the phaae, a pulse of radioactive phosphate

was given and the bacteria transferred to a medium containing
the normal lighter isotopes of C'!rbon and nitrogen; bence all

new cell components made after phage infection were made with
a light isotope.

The cells were then broken open and the extract

was put in an ultracentrifuge into a gradient of cesium chloride
to .eparate the different components.

In this way. it was

possible to distinguish ribosomes made before phas,e infection
(heavy) from those made after phage infection (light).

In

addition. the new m-RNA made after the phage infection. was
characterized by bein& radioactive with p32.

From the position

of the ,32 labeled new mesaen&er FAA in the gradient. it was
evident that the newly synthesized m-RNA formed after phage infection was associated with the old ribosomes.

This indicates

that the m-RNA, after being. formed on the DNA, becomes asso-

c1ated with preexisting ribosomes to form the active polysome
complex.

Oras, Watson, and their colleagues demonstrated the formation of m-RNA in uninfected baeteria (3S) (36).,
cultures of E.

They exposed

Which had been starved of uraCil, to a 30
14
seeond supply of C -uracil, followed by varying times of exC21~

posure to C12 .uraeil.

They then looked for the appearance of

this F.NA-speeific label in the eell extracts, separating the
various components in a suerose gradient ultracentr1fugation.
The radioactivity measurements ahowed a rapidly labeled peak in

-14-

a region between the a-RNA and the 30S ribosome peaks.

Thi.

peak of radioactivity represents the newly formed m-RNA.
In a second part of the experi.ent. the bacteria that bad
been exposed to the short pulse of C14-uracil were incubated
with unlabeled uracil lonS enough for the m-RNA to decay (20
minutes).

The radioactivity pattern now follows the contours

of the 30s and 50S ribosomal peaks. indicatina that the m-RNA
bas been degraded and the radioactivity incorporated il\to ribOSomal RNA.

Thi. instabiU.ty of the maRNA I.a more characteristic of
baoterial syat. .s than of some mammalian systems.
shown. for example. that the

m-RNA

It has been

of reticulocytes 1s stable

over a coosideral) 1e period of time (71).

However t before

Buccessful generaliti •• may be ma.de. it will be neces.ary to
study them-iNA of many more type. of mamma 11al\ systems.

$IRVCTUR&; OF POLYRIBOSQ'M;:S
It was observed that the ribosome fractions most active in
protein synthesis in

~I ~0f.i

were th.ose witn a sedimentation

constant higher than 70S (89) (101).

It appeared from this that

certain claise. of heavy ribosome. were perhaps the primary site
of prote1n synthesis, with the sm.aller ribosomes being degradation products of the larger aggregates.
The most convincing dem.on;:;t:ration of the existence of polysome. came from an examination of the molecular size of the

-1S.

active ribosomes that synthesize hemoglobin in rabbit reticulocytes (30) (72) (106).

When the cells a.re broken by drastic

methods, ultracentrifugation in a sucrose gradient shows mainly
ribosomes with a sedimentation constant of 76S.
6

molecular weight of approximately 4 x 10
usin&la ribosomes n or monoribosomes.

These have a

and a.re referred to as

i;.!'ben the reticulocytes

are incubated with radioactive amino acids before lysis, the
radioactivity is associated with the 76S particles or mODoribosome..

There is also radioactivity present in the soluble

hemoglobin. but this has a much lower sedimentation constant of
approximately 45.

The.. same purified monoriboaomes may be

used to incorporate radioactive amino acids into protein, but
the amount of soluble hemoalobln that can be made is very small.
If. on the other hand, the reticulocyte. after incubation
with radloactive amino acids are lysed very gently by lowering
the ionic strength, the sedimentation pattern contains a heavier
peak with a sedimentation constant of 1703 in addition to the
768 peak of the monoribosom.s.

Even more significant is the

fact that the radioactivity (which 1s pre.uraedly associated
with newly formed protein) ie found almost exclusively in this
heavier ribOlcaull peak..

There is allo a peak of radioactivity

in the 45 fraction which corr•• ponds to soluble hemoglobin.
The•• active heavy ribosomes have been named polysomes and

calculations from their sedimentation conatanta indicate that
they contain an average of five 76S particles each.

-16Electron microscopic examination of this 170 S peak showed
clusters of ribosomal particle. whereas a stmilar examination
of the 768 peak showed almost exclusively single particl.s (106).
The average number of monoribosomes per polyribosome was five,
with fewer clusters of four and six.

Preparations of such

polysome. stained for RNA with uranyl acetate show very thin
threads between the ribosome particles on the polysome.

It seems

likely that these threads correspond to the mes.enger RNA on
which the five single ribosome particles are aligned.
A mode of action of the polysome in protein synthesis has

been proposed by Warner, Knopf, and Rich (105).

Single ribosomes

are supposed to move alona the length of the m-RNA, synthesizing
a polypeptide chain as they progress.

When they reach the end

of the m-RNA (i.e. the end of the polysome), they falloff and
release the newly formed peptide chain.

As one ribosome leaves

at one end of the m-RNA, a new empty ribosome is supposed to
attach itself at the other end to besin its travel along the
template.

Simple variations of thil scheme have been sussested

to account for the formation of protein dimers which. are found
in many proteins such as hemoglobin.

This mechanism of action

should be taken al conjecture or as a plausible hypothesis.
rather tban as an absolute mechanism since there is no compelling
evidence.

-17ASSEMBLY OF A PEPTIDE CHAIN
The question of whether a protein is synthesized in a
linear fashion from one end to the other or whether it might
grow from the middle outwardS \".s investigated by Dintzi8 (25)
(81).

For his studies, he used a system of rabbit reticulo-

cytes, since the only protein synthesized there in quantity is
hemoglobin.

He began by assuming that at any point in time,

there are a large number of hemoglobin chains in varying degrees
of completion in the biosynthetic process.

In a short incuba-

tion with tritiated leUCine, only those chains which were near
completion would be completed and released as soluble hemoglobin.
Further, the position of the leueine-a3 would indicate the portion of the chain which was completed last.

~

hydrolysis of the pulse labeled hemoglobin.

Dintzis found

means of tryptic

that only the four peptides near the carboxyl end of the chain
were significantly radioactive.

This and several other experi-

ments employing longer incubation times led to the conclusion
that the hemoglobln chain grows in a linear fashion beginning
at the N-terminus..

This same conclusion ,,,as reached for hemo-

globin synthesis by Bishop, Leaby. and Sehweet (8) and for
bacterial amylase by Yoshida and Tobita (117).

The same eon-

elusion has been reached by Anfinsen and Canfield (14) for
chicken lysozym.e, so the phenomenon appears to be quite general.
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Pol'i'i"bonucleot1des and the Genetic C04e

In 1961, Nirenberg and Matthaei nlade the discovery. that
synthetic polyribonucleot1.des could stimulate the incorporation
of labeled amino acids into

pf:~ptide-l1.ke

free system from E-Col1 (84).

material in a cell-

In part1.eular. they demonstrated

that poly U, a high molecular weight polyribonucleotide con-

taining only uracil. stLmulated the incorporation of phenylalanine into a protein-like material.

Furthermore. only

phenylalanine was incorporated to any extent.

t~lrenberg

also

showed that the incorporation of phenylalanine required
phenylalanyl-s-RftA as a necessary intermediate, and in that respect resembled protein synthesis.

Fram this result, and

assuming the validity of a triplet cede, Nirenberg and Matthaei
deduced that the code for phenylalanine at the m-RNA level 1.
UUU.

Similar

.xper1men~s

have also been carried out in a number

of mammalian systems prinCipally derived from reticulocyte.
and mammalian tumor eell. (l08). and in the •• it is also noticed
that poly U will sttmulate specifically the incorporation of
phenylalanine into peptide material.
Through the us. of synthetic copolymers (produced by the
enzyme polynucleotide phosphorylase) containing different
proportions of

two

or more bases. the incorporation of amino

acids other than phenylalanine bas been investigated in the
laboratori•• of Nlrenbera (83) and of Ochoa (97).

This type

-19.
of experiment

~ave

the cod. letters for a given amino acld, but

could not g1 ve the seoquel"!.ce of the letters.

for alanine was found to

eon~ipt

they might be in the sequence
More

Henee the code

of the three letters CeG but

~C

or

Gee

just as e.slly.

reeently, Nirenberg and I,edar (59) sh014'8d that tri-

nucleotides of known sequenee will <fireet the specific .ttachment
of particular amino acyl-e-RNA moleaule. to ribosomes.

ror

example. the trinucleotide GUU allowed attaehment of valyl-sMA but not of others.

FurtherPlOrA t the trinue le()t1de. UGU and

UUG were not effective.

~rom

this experiment, 1t appears that

th$ sequenee of the cadii'll triplet for valine 1s GUU.
mannGr, the entire genetic oode is
It

"liaS

unfoldin~.

discovered by the prevl.OUs experiments that many

amino aeld8 have more than one

to them.

In thls

~roup

of code letters a.signed

Thls ls the so-eallad desenaracy of the codlng (18).

This implies that a m-RNA

tampla~e

can provide

f~r

the inaer-

tion of a given amino acid into the peptide chain by more than
one triplet of 'a8sl.

Henee we would deduce the extstence of

mora than one I-RNA specific for tbat amino acid.

It bas been

shown by eountereurrent distribution methods (32) that s-RNA
will yield more than one fraetion capable of incorporating the

amino acid leucine.

ThlR supports the eoneept of eodift8 degen-

eracy. but the true 8ignlfleanee of thl. phenomenon remalns
to be .atabllsbed.

-20Symmap:

The beginning of this chapter delineated the S steps in
the so-called clasaical scheme of protein biosynthesis.

It

should be apparent at this pOint that this scheme is not wrong
in any .ens., but mer.ly over-s1m.plified.

The first two steps

(amino acld activation and transfer to a-RNA) occur exactly as
written.

Recent knowledge hee shed some light on the specifi-

city of the enzymes and of the a-iKA and on the structure of
the s-MA.

But for the moat part, th.s. two steps remain today

exactly as they are written.
The

greate.t advance. of current theory of protein bio-

synthesis lie in the elucidation and expansion of the third
step.

We now recognize the existence of 30s and 50S riboeome.

which may associate to form the 70S particle.

A number of 70S

partieles may unite with a strand of m-RNA to form the active
polyribosome.

Current theory also tells us that the short-

lived m-RNA contains the code which directs the amino aCids to
their proper positions In the protein molecule.

Much of this

cod. has been elucidated by the us. of synthetic polyribonucleotides.

Yet in spite of all thia sophistication, the basic

scheme remains unaltered in seneral outllne.

Hany uncertainties

regardins specific detal1s stl11 remain. and these will be
subject of much reaearch 1n the year. to come.

CHAPTER II
DIA;l§T~S.

INSULIN.

Mill.

PltQIJUN METABOLtStl

Uilb'kaS And PEotlin M,taboll!!
Very early experlmenes indicated thae there was a defect
in protein metabolism aS8eteiated with diabetes.

By 1889, von

Maring and Minkowaki (76) demonstrated that panereaeectomy
results in an increased excretion of nitrogen during fasting.
This observation, which was subsequently verified in numerowt
labor~torie..

led to the COnclusion that pancreatectomy resulted

in either a decrease in prot.in synthesis or an increase in
protein oat4'1>oli_. Or perhapa a combination of th.8 two.

When

the work of Levine and coworkers (61) (62) demonstrated that
insulin affects the permeability of the cell wall to carbohydrates, a mechani.sm wa. senerally accepted whlch considered the
effects on protein synthesis to be secondary to the effects on
carbohydrate metaboli_.

According to this view, carbohydrate

utiU.zation 1s depressed in the diabetiC anlmal due to lack of
insulin. and hence protein is catabolized to serve as a source
of energy for the cell.

'this theory a.sumes that the increased

nitrogen excretion following pancreatectomy 1s due to an increased catabolism of prote1n (60).
However. When radioisotop•• were applied to the problem,
this hypothesis was seen to be an over.... implific.tion.

Krahl

reported (56) that ehe lncorporatlon of glyclna.l_C 14 lnto

glutathione of llvar .llca. wa.,reatly reduced in .evere

... 22 ..
diabetes, .s was the incorporation of both glycine_l_c 14 and
phenylalanine-3-C14 into the protein fractions of both liver
and diaphragm.

This depression of incorporation of glycine.

l_C 14 into protein remained relatively the same '(men the glycine

concentration in the incubation medium was increased by a
factor of 40.

Fran this it was concluded that the net decrease

in glycine-l .. C14 incorporation into protein in diabetes is
attributable larsely to decreased synthesis. although a limited
concurrent increase in catabolism cannot be excluded.

It was

later demonstrated (52) that the degree of the defect in protein synthesis increases in proportion to the duration and
severity of the diabetes..

Penhos and Krahl (86) showed that

this was true for animals made diabetic by pancreatectomy as
",ell as for animals subjected to treatment wt.th alloxan ..
The precedtnt experiments demonstrate a decrease in the
incorporation of radioactive amino acids into protein in the
diabetic animal using tissue slices (liver or diaphragm) as the
meana of protein synthesis.

Korner (SO) showed that the same

re.ults obtain in a eell free system.

He showed that both the

mitochondria and the microsomes isolated from the livers of
alloxan-diabetic rats incorporate 1••• radioactive amino acid.
into their protein in :4$[0 than the corresponding subcellular
particles prepared from the livers of normal rats.
By a .erie. of cross-over experiments, he demonstrated

that the impairment in protein Iynthesis caused by diabetes is

-23found at the m.icrosomal level.
ing manner:

This was decided in the follow-

A group of both normal and alloxan-diabetic rat.

"..rere sacrificed and the liver microsomoa and cell .ap laolated.
A ••"ies of incubations was then performed in which four combinati.ons of these were tes'ted.

'l'he first &roup cOl'ltained the

micro.ames and cell sap isolated frotll the noma.l aniJaala.
gave

4

This

control rata of incorporation of the amino acids into

protein.

The second group utilized the microsomea from normal

rats but the cell sap from alloxan-diabetic animals.

Tbis re-

sulted in values of incorporation only sllgiltly lower than
thoa. obtained for the control. i.tu'u.catin& that the diabetic
condition affected the eell sap only 8lightly.

The third group

utilized the cell sap from nomal animals but the mi.crosomes
from alloxan-diabetie ones.

Thi. showed a large inhibiticm of

incorporation, virtually as camplete as was obtained in the
fourth group which utiliz.,d both the microso.'Ues and cel.l sap
from diabetic animals.

Korner therefore concluded that most

of the decrease in incorporation of amino acids shown by the
microsomal system pr.p.nd f r . livers of alloxan-diabetic rats
is caused by a.lterations in the ability of the Iaierasome. to
assamble the amino acids into polypeptide chains.
that some

depress1.n~,

But be admits

effect on the ability of the soluble frae-

tion of the liver to prepare amino acids for: incorporation i .
also found in alloxan-diabetic rats.
A similar seri •• of experiments was performed by Robinaon

-24.
(91) Who concluded that liver microsom•• from .everely diabetiC

rats incorporate leucine... l-C14 into protein at a lower rate
than microsome. from control rats.

His data led to the con-

clu.ion that the.e change. oecured specifically in the microsomes; there was no difference with respect to ability of
soluble fractions to activate microsomal incorporation.
More recently, Rampersad and Wool (90) have demonstrated
that the incorporation of phenylalanine into protein by isolated
ribosomes from the he.rt muscle of rats is decre.sed when the
ribosomes are obtained from alloxan-diabetic animal ••
Thus it bas been .hown that diabetes caule. an inhibition
of protein synthe.i. in ti ••ue Ilic.s, in microsomal cell-free
systems, and in at least

Ofte

ribosomal system.

It has further

been postulated that this defect in diabetes is to be found at

the microsomal (or ribolOllUll) level.
Ih, §fftst, of Inlulin !dmlnlls£,Clon 1n !lV! on fEotein
Mtta!1!U••
There is a wide range of conflicting early reports in the
literatu.re concerning the effeets of insulin on the growth of
an1mall.

Some of the conclusions are invalid because they

were performed on fasting animals.

There se_s to be complete

aare_ant that the administration of insulin does not cause
demonstrable protein anabolism in the fasting animal (9) (29)
(31) (94).

There is conclusive evidence that in the non-

-25fasting animal insulin tends to cause protein anabolism .s
indicated by a positive nitrogen balance (44) (51) (65) (94).
However, this tendency of inlluU.D to produce a positl'W nitro~en

balance bas not led to arowth in normal an1mal. (28) (41)

(42).

The elassical experimental results of the influence of

insulin on protein metabolism have been summarized 1n Table 1,

modified from. Lukens (65).

In contrallt, the evidence from radloisotope experiments
is much more eompellin& than the whole animal experi..ments thus

far d •• ert.bEtd.

In the isotope experlments, an animal is in.

jeeted with insulin and the ability of it. liver (diaphragm,
heart etc.) to incorporate amino acids into prote1n is

lisr9

is compared with that of a control animal injected with saline.

By usinS this technique, Robinson (91) has shown that the
micrOS0tU8S from the 11vers of normal rats incorporate amino
acids at a bisber rate after the injection of insulin.

S1milarl~

Korner (SO) d_Oftltrated that the treatment of alloxan-diabetic
rats with insulin r.stored towards nOJ:Dl4l th. d.pr••••d 41>i lity
of both mitochondria and microsom•• to incorporat. radioactive
amino acids into protein.

This restoration wal .hown to be

dependent upon the dosage of insulin lnjected.

TABLE 1
STUDIES

or

THE INFLUENCE

or

INSULIN

ON PROTEIN METABOLISM
1.

Pancreatectomy results in an increased catabolism of endo-

genous protein .s evideneed by an increased nitrogen
excretion during f.sting (16).

Insulin treatment of the aepancreatectomized animal. or of
th... severely d1abet:1c patient prewnt:s this acceleration of
prot:e1n catabolism (2) (16) (27) (58) (94).
From ia.lil! stud1es on the disposal of N1S.glycine. there
is 8ame evidence that: protein synthesis is defective and
protein breakdown exce.sive in the diabetic animal (40).
II.

Insulin ,iven to nOl."fU.l animals:

A.

B.

Investigators who failed to observe protein anabolism:

1.

No increased growth of rabbits (64).

2.

No effact on fasting nitrogen balance in rats (9).

3.

No

4.

No change 1nnitr08_ excretion (43).

5.

No effeet: on 8.;t'owth of rats (28) (41) (42).

effect on growth or nitroljeft excretion of normal
rats with or without control of diet (31).

1Dvestisators who concluded that insulin promotes protein anabolism.:
Glucos. and insulin spar. more protein than
alone 1n normal subjects (44).

2.

~luc08.

Insulin cau ••• positive nitrogen balance in fed
normal dOg8 (94).
Insulin cause. nitrogen retention in normal rats.
with. or without constant d1et (65).

4.

There i • •een a positive nitrogen balanc.1n patients given insulin (51).

5.

Liver and diapl1ragm incorporate more labeled amino
acid U1.'ld,r influence of insulin if gluco•• is
present \53).
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lbi In VLeEt
1.

E(f!es-

of InluliA

URon Is0 1ated

It.aue,

Effect on Muscle
The rat diaphrap haa been widely used as a represent-

ative mulcle since it

eLm

be readily isolated and incorporates

amino acids into its protein, apparently chiefly in peptide

linkaf)fI (10).
Sinex .!I

!1 (93)

and Krahl (56) independently observed in

1952 that the incorporation of slycine-C14 or alanine_C14 into
protein of ciiaphrapta from feet rate was enhanced by the

ntEo

ad~ition

1.n

of insulin to the incubation medium in the

ab.enee of added glucose.

Manchester and Young (68) demonstrated

this effeet of insulin upon the incorporation of 9 different
radioactive amino acids both in the presence and absence of
added

gltlCOS.

or pyruvate.

They furtber noted that neither

glucose nor pyruvate alone had any .ffeet upon the incorporation.

The•• results seamed to indicate that the f1tffect of insulin on

protein metabolism in this ea •• was independent of it. effect on
glucose transport.
Several control experiments were made to exclude glucose
transport a8 the basis for the insulin effect (115).
were

thorou~hlY'

Diaphra~.

washed in !lueose-free medium before transfer

to the final incubation medium; .no free .glueofte eOltld be detected
by analysis of the wtluthed muscle.

Th. dia.phragms were then. in-

cubated for 2 hours at 37°c without glucose or insulin, then
transferred to a fresh medium with or without insulin and

-28incubated for an additional 2 hours in the presence of a radioactive amino acid.

Insulin atill produced a significant

st~

ulation of incorporation. although any glucose carried over by
the donor would have benn exhausted in the first 2 hour ineubation.

It was further observed that the addition of large

amounts of glucos. to the medium did not increase the amino acid
incorporation by diaphragms from fed Sprague-Dawley rats (115)
nor by diaphragms of 24 and 48 hour fasted Wistar or hooded
rats (69) under the same conditions in which insulin alone was
effective.

These experiments are all taken to indicate that

inlulin can stimulate amino acid incorporation into protein by
a mechanism which does not depend on glucose transport.
On the other hand, experiments performed

~4ith

fasting

Sprague-Dawley rats showed a different effect (116).

As the

period of fastin, increased, insulin alone had le81 effect in
the abaenee of glucos..

When glueos. was added to the medium.

the incorporation of amino acids was increased marginally, but
the capacity to r.spond to insulin was fully restored.

These

r.sults were taken to indicate that under certain conditions the
supply of

ener~y

or of intermediates from carbohydrate metabolism

apparently becomes limiting and then the tnaulin affect on
amino acid incorporation

b~eomea

dependent on the transport of

extracellular glucose into the muscle cell.
In 1960, Wool verified that the inSUlin effect on the incorporation of hiatidine-2-C14 into the protein of diaphragm

-29from the 48 bour fasted Sprague-Dawley rat vas directly proportional to the glucose concentration in the range of 0 .. 600
m&% (114).

ae noted, however, that a number of other sugars,

noteably D-manno •• , D-xyloae, D-ribose, and L-sorbose were a.
effective as @lucoa..

Since the last three are not utilized by

diaphragm muscle, be conclude. it is unlikely tbat the positive
influence of carbohydrate on protein metabolism derives from its
ability to increase the energy available for protein synthesis.
Experiments involvins the metabolic fate of these sugars failed
to show any correlation between their metabolism in diaphragm
muscle and their ability to restore the iusuli.n effect (112).
Although it now se..a likely that the

1D

v~~~~

effect of

insulin on protein synthesis in the rat diaphragm is not a
.econdary effeet due to a primary effect on glucose transport,
there is much speculation on the true mechanism of action of
insulin.

The discovery that the transport of

aeid into isolated rat

diaphra~

~-aminoisobutyric

waa increased by the in visro

addition of inaulin led to the interesting possibility that insulin affected the transport of amino aeid. into the cell in
mueh the same way as it affecta the transport of glucos. (49).
Unfortunately, this reasonable explanation was disproved by Akedo
and Chriatensen (1) who discovered that, althoug,h insulin does
affect the transport of several nOD utilizable amino aCid., it
bas no effect on the majori.ty of th.e natural amino acids.
Further. the inaulin stimulus is still .een when the labeled

-30..

amino acids are formed intraeellularly from radioaetlve precursors such as bicarbonate, acetate, citrate etc.

(61).

The most recent' theory proposed tor the protein anabolie
action of insulin is thFtt it somehOw affeets the formation of
m-RI'lA, perhaps by eombining with the represlJor gene, maJdng it

unable to combine with the operator and henee leading to the
synthesis t)f more m-RNA (113).

Tbis particular theory is

under intensive study in

laboratory at th4!J present time.

11.

1"'001.' s

Effect on Liver
Krahl (52) (55) (56) reported that the capacity of

liver slice. to incorporate glyeine-C14 into the peptide glutathione or protein was

1mpair~d

in liver 811e81 frtlm alloxan-

diabe't'ie rats, the desree of the defect being in direct proportion to the severity of the cU.abet...

No direct 1D nt[2 .ff.et

of insulin could be demonstrated wi't'h alic.s from the mo.t
severely diabetic animala, 81t11.ou3h restoration of normal incorporation could be aebleved by injeetion of insulin and the
pa ••age of 10 hour. or mor••
The situation with liver alia•• from mildly diabetic rats
was, however, quite different:

insulin added

.!n vitrg raisftd

the incorporation of glyeine-C14 into slutath10ne or protein if
slueo •• was also present; S\luens. alone had a slight .ffect,
in.ulin alone !lad none..

Th&.... experiments were later repeated

by fenhol and Krahl (86), u.1ftg liver allee. from both nonal

and partially depancreatized rats at variOUS times after paner••.•

-31removal.

The r.sults fully confirmed and extended the earlier

W'Ork in d __ atrating:
A.

that insulin stimulate. amino acid incorporation into

liver protein when added 1a vilEO

B.

that this effect depends on tbe pre••nce of ,lucole

C.

that the stimulation is areater with slices fro. mildly

insulin-delicieat animaL. than with those from either
normal animals or 10ll& tem diabetic animale.
that this

D.

in Yili2 effect of insulin requires 2 - 3

houri to become maxillal.

The conclusion derived from this work il that insulin can act
directly on the liver to stimulate amillo acid incorporation into
protein

by

111.

a mecbanism dependent upon the presence of glucal:3e.
Effect on Adipose Tissue
Labeled amino acids are rapidly incorporated

ia

VitE2 into the protein of rat epididymal adipose ti.sue (37)
(54).

The incorporation of the labeled amino acid into protein

is enhanced by insulin only wben same carbohydrat. substrat.,
such •• pyruvate or glucose. 1s present in tbe medium.

In a

more recent report (57) it is mentioned that both pyruvate and
Cluccs. alone stimulate incorpor.tion, but pyruvate plus insulin
or glucos. plus insulin Sive a significantly treater incorpor.tion.

fio iner.... in incorporation was noted if insulin vas

added to the medium in tbe absence of either pyruvate or glucose.
The mecbanism of the stimulatory effect of insulin upon

incorporation of amino acids into adipose tissue protein has
been part!.ally explored.

It is evidently not concerned with

stimulation of glucose transport. sinee it CAn be produced in
the absence of glucose if pyruvate is present.

The insulin

stimulus is obtainable when the amino aeid is formed intracellularly from a precursor such as pyruvate.C14 and thus does
not appear to be concerned with the transport of amino acid
from an extracellular to an intracellular phase (54).

It is to

some degree specific for the incorporation of amino acids into
protein, as the conversion of pyruvate..C14 carbon to alanine in
protein may be stimulated. while the incorporation of the

~:'\;3m.

carbon into fat of the salDe pieee of tissue is not (54).

Hence

it appears likely that the insulin

.:s acting specifically upon

same process concerned with protein synthesis.

IV.

Effect on Cell.Free System
If a cell-free system could b. devised in which the in

vitro addition of insulin would accelerate protein synthesis.
it would be a great boon to research 1n this area.

To date,

there has been no recorded instance in which insulin added in
vit[2 has been shown to increase protein synthesis by a cell-free
microsomal or ribosomal system:.
the addition of insulin J:n

Robinson (91) reported that

nt£o to a microsomal system from

normal rat liver was totally without effect.

Manchester (66)

notes that no such effect bas been found in any broken cell
preparation.

Recently. \-1001 (90) has added insuU.n .1!1 yitEO

to ribosome. from heart muscle

and

found that it did not affect

the ability of the particles to catalyze the incorporation of
radioactivity fram • lUiA-phenylalanine-c 14 into protein, whether
or not polyuridylic acid was pre.ent.

Hi. own words aptly

describe the situation at the pre.ent tlme.
-The lack of effect: of the homone when it is added .&a yj.&i9 to
the cell-free system is a diaappointment. but no alteration of

the experimental desian or circumstances has yet Changed the
outcom....
The various

J.u.

nSro

effects of insulin upon protein metabolism

in isolated tissu.. have been summarized in Table II.
Illl Iff.sts Sf Ill. Qral

HDo&lxeEie,~!ntl

In the past deeade or

80.

on r§,ot!itl Smt.b~

a n\J.'lRber of oral hypoglycemic

compounds have gained prominence .s a substitute for insulin in
the treatment of certain milder type. of diabetes mellitus.

Two

of the most interesting of th••• agent., repr••entin! different

classes of chemical compounds, are tolbutamide and phenethylbiquanide.

Whereas the former is thought to exert itll effect by

stimulating the deficient pancre.e to produce more insulin. the
latter almost certainly act. by a different tnechani_ (21) ..
Nonetheless. both of the•• compounds are able to adequa1:ely control the blood sugar level of mild diabetiCS when administered
orally..

The chemistry of the oral hypoglycemie agent. haa b.en

reviewed previou.ly by DeChatelet (21).
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'tAStE 11
IN VITRO EFFECTS OF INSULIN UPON ISOl.ATED TISSUES

I..

}>fusele
A.

Diaphragm. frOln fed rats
A response to insulin i8 obtained without glucose in
th~ medium.
This cannot be reproduced by the addition
of exo$enous glucose to the medium. This insulin
stlrmJlu, to protein synthesis is not aecort'tpanied by
any stimulus to accumulation of natural L-amino acids
by the diaphragm.

B.

Diaphragm from fasted rats
The incorporation of labeled amino acids into protein
1s lower than in diaphraps from fed animals. In some
specie. of rat. insulin 1s effective only when glucose
is added to the medium, but a number of non-utilizable
sugars co\11d substitute for gluco•• in this regard.

II.

Liver
In iRolated liver, .s in musele, the incorporation of
amino acids into protein is reduced after prOduction of
diabetes in the donor, the reduction becoming greater
.s the intensity of the diabetes increase.. The iD
vitro addition of insulin enhance. amino acid incorporation into proteln, but this effect is dependent on the
presence of glucos. 1n the medium. The insulin stimulation 1. area,e.t in livers from mildly diabetic rats,
and cannot be demonstrated after severe diabetes,
accompanied by weisht 10•• and ketosis, sets in.

111.

Adipose Tissue
In isolated rat epididymal adipose tissue. insulin
alao enhance. the incorporation of amino acids into
protein. Thi. stimulation cannot be obtained without
the addition of some oxidizable ~lbstrate such .s glucose to the medium. But the insulin effect is not dependent on glucose transport as it can be obtained when
pyruvate is aubstituted for 81\1cose.

Although there has been

&

~reat

deal of work devoted to

the influence of insulin on prQtein biosynthesis, the problem
of the influence of the oral hypoglycemic: agents on protein biosynthesis has been lat:'gely ignored.

In 1957, Recant and Fischer

(88) reported an eXl'er1rnr:nt involving the oral administration of

tolbutamide to rat's for a period of five days.
the animal:9

~erE!'

On the final day,
14
saerifieed and the incorporation of glyetne-C

ir";o liver slice protein was measured and compared with that of
normal rats.

The authors reported that the ability of the liver

slices fr<XR the tolbutamide treated animals to incorporate amino
acids into protein was sig..nificantly greater than that of liver
sllces derived from normal an1mals.

They further noted that a

single acute i.njection ot tolbutami.<Hi produced no effect.

The ••

results are entirely consistent with the proposed mechanism of
action of tolbutamide; if tolbutamide acts to increaae the production of insulin from the pancreas, then the additional insulin
present would be expected to have an anabolic effect on protein.
It a_a likely that Recant and Fischer were actually measuring
an insulin effeet, rather than a direct effect of tolbutamide.
A little later, in 19S8, a disquieting note came fram the
laboratory of Manchester (70).

\lnil. investigating the in-

corporation of alanine-C14 into isolated rat diaphrap, he
noted tbat this incorporatlon i8 depres.ed in the presance of
either tolbutamide or carbutamide resardl••• of Whether glucose
or pyruvate waa prea.nt in the medium.

A concentration of

-36tolbutamide of 10 millimolar gave an incorporation which was
only

9~

of the control level.

Since this effect was seen using

isolated tissue, it is a direct effect of the agent. separate
from any influence on insulin production.
Here the matter rested W'ltil 1964 wben Jarrett and Butter·
field (45) amplified the experiments of Recant.

They reported

that a concentration of tolbutamide of 10.2M depressed the incorporation of leucine.C 14 into the prot.in of diaphragm from
nor,mal rats.

This eff.ct was marainal at a tolbutamide coneen-

tration of 10-3M and was not ••en at lover concentrations.

Th."

further reported that the catabolism of leucine. as measured by
014 O2 evolution was similarly depr••••d by the presence of
tolbutamide.
Th••• results were extended to a liver homogenate .ystem
by DeChatelet and McDonald (22) who reported that both tolbutamide and phenethylbiquanide depre.sed the incorporation of
leueine_C 14 into hepatic protein independently of the glucose
concentration.

The inhibition s.en by the.e two agents was

quite different 1n ebaracter and corresponded well with a eoncommitant inhibition of leucine catabolism.

More recent exper-

blents (74) have shown that this inhibition of leucine incorporation 1s also evident in a microsomal system derived from the
livers of normal and alloxan-diabetic rats.

Thus it appears

likely that these oral hypoglyc_ic agents are. in thems.lves.
inhibitor. of protein biosynthesis and do not mimic the action

-37of insulin 1m thi s reapect.

In fac:t t their effeet mir-,ht W'ell

be c:onsidered to be antagonistie to insulin with regard to

the biosynthesis of protein.

CHAPTER III
r1ATERIAltS ANO l1EJHODS
Glm§RAL EXPERIMENIAL RROStE:DURJ;

The experiments described in this di •• ertation may be
divided into two general eatea0rie.:

thoae in which tbe addi-

tions were made to a protein synthe.izing SYltam

In USEO and

tho •• in which a eompound wal injected into an animal
and its effeot measured

ill vj;tiO.

.1n .J1!'2

The first type of experiment

was performed in the following manner.

Ff'.llImale Holtzman rats, fed

U &:&:bl£W9

diet. were saeriflced by decapitation.

Oft

a standard stock

The livers were removed

without delay, washed in ice cold buffer, blotted, weighed, and

homosenlzed in cold tria buffer.

The homogenate was centrifuged

for 15 minute. at 10,SOO r.p.m. to remove nuclei. cell debris,

and mitochondria.

Tbe supernatant solution was carefully

deeanted and centrifuged at 100,000 r.p.m. to sediment the
mierosomal fraction.

A portion of the cleareell sap was care-

fully siphoned off the microsome pellet by means of a hypodermi.c
syri.nse, and the remainder of the sap was discarded

II

The

microsome. were resuspended in buffer by gentle homogenization
so that a total volume of 0.4 mI. of homogenate contained the
microsom•• from one gram of liver.

Flasks were incubated at

37° C, usually for a period of 2 hours.

Each incubation flask

contained 0.40 mI. of microsomal suspension; 0.30 mI. of cell
sap; 0.30 mi. of premix; and 1.0 u curie of leueine.C14 •

In the earlier experiments 1.1:

\<7aS

desired to study the

effect of various cofa.ctor9 upon the inecn."poration of leucine.C 14
into hepatic protein.

Accordingly, the cofactor under stu.dy was

omitted from the premix and adde('! separately in the desired
concentration to each flask.

Later experiments were concerned

with the effects of various oral hypo&lyeemic agents on this

incorporation.

In these cases, the complete premix was used and

the various additions made separately to each flask.
The other series of experiments involved injecting an intact animal with a dose of the agent under study.

Aftor a

specified period of time the animal was sacrificed, its liver
removed, and the same incubation procedure utilized a.a before.
These ex:per1menta involved both the effect of a single large
injection of agent and of a smaller daily injection over a period

of time.

Control values ".tere obtained bytha injection into

other rats of an equimolar amount of sodium chloride.

It wall

necessary to employ litter-}uates for maximum reprGduceability

in the•• expertBents.

Adenosine.S'-triphosphate, elisodium salt, Sigma. grade.
Chemical Co., St. 1..oui8, Mo.
Alloxan, monohydrate.

Sigma

lot I 14B-1090

Eastman Kodak Co.. ROChester. N.Y. lot

41 1722
Cas.1n hydrolysate, acid.
Cleveland

Ohio.

Nutritional Biochemicals Corp.,

lot II 8809

Chlorpropamide. sodium salt:.

'lorl(.. N.Y.

Charles Pfizer and Co. Inc.. New

lot 11 03-422-02EFD

Cr$4tine phosphate, disodiurn salt. A ired •• Calb1.ochem. Loa
Ang. les, Calif.

lot·jj 60147

Creatine phosphokinase, A

~rade.

Assay 20 E.U.'mg_ protein.

Calbiocn.m. Los Angel•• , Calif. lot I 53714
Clueos., C.F. Malllnkrodt Chemloal Works, New York, N.Y.

lot

, 4908

Glucostat, Worthin&ton Biochemical Cot:p., Freehold, N.J.
lot # 1015
Guano.tn. triphosphate, tri.sodlUUl Mlt, A-grade, Calblochem,
LOI

Ana.les. Calif.

lot" 60214, $0272, 64582

i-Iapaalum Chloride, Baker Analyzed It_,ent.
i.cal Co •• Phll11paburth N.J.

J. T. Baker Chem-

lot I 7117

Pbene'ttwlblguani.de, hydrochloride. O.S. Vitamin Corp •• New York,
N.Y. lotI 21

Potas.ium. Chloride A..R., Malllnkrodt Chemical 'Wort",. New York,

N.Y.

lot # 6858

Sodlum chloride A.R •• MalU.nlttodt Ch.lcal Works, New York.
III '" Y •

lot 11 7S81

Sodium hydroxlde A..R •• Malllnkrodt: Chemieal Works, Nw York,

N.Y.

lot I 7708

Sucros •• A.R. Malllnkrodt Cbemleat Works, New York.. N.Y. lot

I 8360
Tolbutamide j .odium .alt. The tJpjobn Company, Kalamazoo, Mich.

lot

~

CJO 11,584-2

Trichloroacetic: acid A.'ll",. t4 alH.nlu:'oc.it ChGmical Works •. New York,

N.Y.

lot /I; 2918

Tria (hydroxy"'nethyl aminGmethane) Primary Standard Grade. Slpa
Chemic.., 1 Co.. St.. Louis II Mo..

lot t? 1125-812

L.Leueine-C 14 (U .L.) .... This was obtained from the New England
Nuclear Corp.

t

B')ston, Mass. and was supplied as the hydro-

chloride dissolved in 0.0111' ;:tel.

Since this exc••• Acid aisht

adveres91y affect the bufter system in the incubation. the

i.otope was evaporated to dr-rness 1n the original vial under a
stream of nl tro13an ga...
hydrochloride)

Tht! dry am.ino acid (present as the

was than dissolved in sufficient doubly til.tilled

water to Siva a final activity of 1 uc/SO ul of solution.

The

aqueous solution was stored in th.e freezer at .. So C and thawed
immediately before

USI!.

The L_leueine_C14 (U.L.) was •• pacially .elected for iDoor-

PQrAtlon into protein studies because of ltB bith specific
activity and relatively

fe,~

metaboU.e pathways.

Its lot # 1.

212-31A-12 and its speeific activity is quoted ns 231 milll.
curies/millimole.

The radiochroraatogram. as determined by the

manufacturer. indicates a purity 1n excess of

auffer •• lue101u

99.8~.

The bufter 801u1:1_ uaed .... that of

campbell aDd Xenot (13) J.n thelr work

Oft

the 1Dco~oratlOD of

radioactive amino acids into serum albumin.

4.240, of tr1a,

1,864 g. of Ke1, 2.033 g of Ma01Z' and 51.35 g. of sucro.e
were dissolved in doubly, .glass-d1st11led water and the rAsul-

Concentrated HCI wa.

tet solution was made up ta one liter.

a.dded until the pH was adjusted to 7.8 as m..sured by

4\

Beckman

pH meter; this required approximately 1.85 ml. of the acid.
The final molarity of the solution with respect to each component
was:

O.03.5Mtris; O.02SM KCt; O.OlM MgC12 ; and a.lSM sucro.e.
Premix Solution:

Two different premix solutions were used,

depend ina upon the experiment.
tion. is given in table Ill.

no

18 !iIEo

The composition of th••• soluPremix 1 wa_ used when there were

additions to be made to the incubation flasks;

ml. of tMs .01ution vas added to each flask.
employed wben

80me

0.30

Premix 11 was

other compound was to be added

.&a ntE9

to

each flask; 0.20 ml. of this solution was added to each flask,
and the other addition was made in a total volume of 0.10 ml.
so that the total incubation volume was tbe same in .::.11 eases.
In experiment. wbere the basic premix differed from that des ...
cJ:lbed here, it will be noted under the particular experiment.

1SO!::,\I I Of!

OF

HlSlU1S91IS

Livers were obtained from ftllll8le rats weighing ISO .. 200
grams which had been stunned by a blow

ficed by decapitation.

Oft

the head and a.cri-

The livers were removed .s soon ••

po.aible after death. usually within 30 .. 60 seconds.

They

TABLE: III
COKPOSITION OF PRiHIX
'{{§MIX 1
SUBSTANCE

CONC.

'miLs.o

ml.)

20,S

ATP

172.5

cre.tine phosphate
creatine phosphokinase

0,8

GTP

PRRjlX 11

SySSTAN9.E
ATP

cre.tine phosphate

cgnc.

(.&/5,0

ml.)

30,8
2.58.9

cre.tine phosphokina.e

1.3

GTP

6.9

These conoentrations were experimentally determined to
sive optimal incorporation of leucine.C 14 into hepatic protein.
(cf. Experimental Chapter. Part 1).

were then rinsed in ice cold buffer solution, blotted dry.
weighed. and ground sently with 2.5 volume. of tris buff.r in
a Potter-Elvehjem type hOlllo,enizer at 700 r.p.m. for 5 complete
vertieal strok... Th. homog.nization process was carried out
o
at 0 C. Unbroken eells, tissue debris, nuclei. and mitochondria were removed by centrifugation at 12.500 &. for 15 minute.
at 00 C.

(Servell Centrifuge Model 8S-1, Serial No. 4796, 9.900

r.p.m., r.c.f. 12,520 at tip).
The supernatant .olution was car.fully decant.d into polyallom.r ultrac.ntrifuge tub.s.

The.e wer. then centrifuged at

10S,OOO & in an ultracentrifuge (aeckman Model L. 40,000

r.p~m ••

r.c.f. 10S,OOO at tip) for 1 hour at 00 C. to sediment the
micro.omes.

The number 40 rotor was used for this proc••••

FollOwing ultracentrifu,ation, the micro.omal fraction
appeared •• a pellet in the bottom of the tub•• while a lipidlike layer was invariably pre.ent at the top.

A portion of the

cl.ar cell sap. s.en between th.se two lay.rs, was withdrawn by
m.ans of a hypodermic syringe and stored in the cold.

The

remainder of the cell s.p, alon& with the lipid layer. was decanted and discarded.

The microsomal pellet wa. rinsed with 1.0

ml. of cold buffer solution and then re.uspended in buffer by
,entle homogenization.

This final .u.penslon was prepared in

sueh a way that eaeh 0.40 ml. of solution would contain the
microsome. derived from one gram of liver.

Each incubation

flask was .tarted by the .tmultaneous addition of 0.30 ml. of

-45cell sap and 0.40 ml. of microsomal au.pension.
PROTglN ISOLATIQ!!

After the flasks were incubated for the specified period
of tim.. the reaction. ware terminated by the addition of 1.0
ml. of

l~

trichloroaeetic acid (TCA).

Thi. prote1n precipitant

haa the advant••_ over perchlorlc acid (PCA) in that it pre·

cipitate. more type. of pla_a protein. (99).

The exact mechan-

iam of precipitation by either of the.e acids is unknown.
Once the reactions were terminated, the contents of each
tlalk were quantitatively tran.ferred to • gla.s stoppered
centrifuge tube and centrifuged for 45 minute. 1n a clinical
centrifuae to .eparate the precipitated protein from the supernatant .olution.

The protein was suspended in 5.0 ml of

TCA by .ean. of a vortex mixer and recentrlfuged.

S'l~

The preci-

pitate was then wa.hed three time. with 95% ethanol and three
times with acetone in the .... manner.

The effi.ciency of the

washes il1 removing non-incorporated leucine.C 14 was determined
by platina out a 1.0 ml. aliquot of each wash, evaporatins it
to dryn•••• and cOUI'ltina the dried s . .p1e with a thin window

Geiger-Mueller Counter.

In another experiment. a 1.0 ml.

aliquot of tbe final acetone wash from each of eleven flasks
was treated similarly.

The data in Table. XXIII and XXIV in

the appendix olearly indioate that the above procedure provide.
adequate purification.

After the final acetone wash., excess acetone was removed
by

gentle suction w1th an aspirator and the preeipitate.dis.

solved in 2.0 ml. of O.lN sodium hydroxide.

A 1.0 mi. aliquot

of this solution was taken to dryne.. in a planchet and
counted in a thin window Geiser-Mueller Assembly oonlilting
of a Tracermatic Se.B) Scaler. Tracerlab $G-iOa Mult1matic
Sample Chan&er. and Tracerlab 5C-66 Printi.n& 'rimer.

Mo correction wal made for the .elf-absorption due to the
.odlU1l hydroxide since titi. wa. constant for eacn sample.

The

geometry of sample• •0 plated wes exeellent; each planchet

contained a unifom thin layer of solid material on the bottom.

Ib29D

GLU~QSi DiXI8HINATlg~J

The detend.nation of blood glucose was performed by a
modification of the Glucostat method (100).

Tail blood was

obtained from tbe animals under study, and the sertL-n separated
from the eell. by centrifugation for 2 minute. 11'1 a 'Seckmaft
Microfuse.

The assay involved adding 20 u liters of sample

(standard or .erum) to a small t •• t tube followed by 2.0 ml.
of Glucoatat reaaen1:.

The tube. were mixed by inversion and

incubated at room temperature for 10 or IS minute..
was terminated by tbe addition of 1 drop of 2

The reaction

Hel and the

absorbance read at 410 m u in the Beekman micro colorimeter.
Preliminary experiments indicated that the absorbance was not
affected by tbe amount of HCI added, so this rather inexact

...47measurement of Hone drop" 1. valid.
~tandard

curves were plotted using this procedure for both

a 10 and 15 minute incubation time.

Fisure 11.

Thes. curves are shown in

It 1.s apparent from the grapns that the absorbance

is directly proportional to tbe glucose concentration over the
ranS. of 0 .. 600 mg:f. for the 10 minute incubation.

Some devi-

ation is ••en at the higher concentrations in the case of the
15 minute incubation time.

The above procedure has the advantage of simplicity over
other more common method., but it i8 not nearly as exact.

The

fact that a protein free filtrate was not prepared was taken
into conslderati.on by running a zero t1me control with each
sample.

There ara otber li.mi.tationa of the mathod uled. but

sinc. it was d4Iailfted to ,lve only an approximate serum sluco.e
lavel (e.g. to determin. whether alloxanized rata had abnormally high blood lugar level) thes. were not felt to be important
anough to justify the more tedious determination involving the
preparation of the protein-fr.. !t.ltrate.

YSE OF

ALLO~~-D!AI&IIC AN'~~LS

In several experiments it was desired to utilize the livers
from rats made diabetic with alloxan.

Prell.minary experiments

ahowed that the animals were much more likely to become dt.abetlc
if they were subjected to a 24 hour faat before the injeetion.

Accordingly, the following procedure was utilized.

-48-

.800

w

u

. 600

15

.

min.

z

«
CD

.4 00

.

a::

min.

0

en .200

CD

«

100

200

MG

%

300

400

500

GLUCOSE

FIGURE II

STANDARD CURVE FOR GLUCOSE DETERMINATION

600

-49Twenty four hours before injection. rats wei8,hing 145 .. IS5
grams were placed in separate metabolic cases and given free
ace.s. to water but: no food.

The urine was collected and tested

for the presence of Slucos. (Clini.tix, Ame. Co •• Elkhart,
Indiana).

In all ea •••• the amount of gluco.e pres.nt was below

the .en.itivity of the test.

The animals were then injected

with 20 ms/100a of alloxan monohydrate in 1.0 ml. of dl..tilled
water and returned to their individual case..
allowed fr.e access to both food and water.

They were now
Urinary Sluco••

and k.tone excretion were checked dai ly (c 1ini.tix and Ketostlx, Ames Co., Elkhart, Indiana).
were ,lucosuric and many

~.re

All the ant.als treated

mildly ketonuric..

The animal.

were .acrificed 48 hours after the injection of alloxan and the
teninal blood sugar value was determined.

In,all ea.e. this

was above SOO mg% and in two ca... was above 2000 1\&%.
It was observed that following the injection of alloxan.
the animals became hyperirritable and each was observed to
lose a sipificant . .ountof wiaht in the three day period.
The data from one such serie. of experiments are 3iven in the
appendix in Table XXV.

C!;!AlIIR I~

WERIM,§,NTAL.R§SULIS
1.

ESTABLISHMENT 0' A CELL.PREE SYSTEM POR. OPTIMAL
INCORPORATION 01 LEUCINE_Cl4 INTO HEPATIC PROTEIN.

Al?:houah the general requirements for the cell·free inoorporation of radioaotive amino aolds into protein have been known
for soma time (11'). there i. still considerable variance in

the literature a. to the proper conoentration of cofactors
nece••ary to ensure llUlXimua inoorporaticm.

An illustration of

this is axhibitad in Table IV in Whioh the cofactor concentratlons used by several In. .stiaators are s"..rized.

lecaus. of

ehe obvious diff.rence•• lt was considered nece ••ary to determine
s . . of the parameters of the protein-synthesiziDg system experblentally in order to aahia... optlmalincorporation.

Much of

the experlmental d •• ip at this staS_ was arrived at in an
arbitrary fashion sinee there were no speclfio guidelines available.

The tris buffer

was chOsen because of its wide usea8e

in somewhat similar experimeats, leuOlne-c14 was .elected a.
the isotope bacau •• of it. hiab spaelfio activity aDd relae!:.,ely
few .atabolic paehways; eraatine phosphate was employed .s the
en.raY .oure. for re.sons of econ_d.cs; faale rats ware used
because of their relative doc111.ty, etc.

It is quite possible

that another investigator might have • very different rationale

and consequently would beain work with a considerably different
system.
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tABLE IV

IRE

CQ-iPOSITION OF INCYBATION MIXTURES USW BY XARIOUS

INVESTIGATORS

T2

SIUUX HIPATIC

PR2Ill~

SYNTHESIS IN A

C!LL-FRE& SISTEM
INU~:rlGAIOR,S

MYRtiiX

COl1PONENT

HIZM!Q. (781

Sucros.

35 u moles/ml.

Tris

SO u mole./ml.

40 u mOle./ml.

MgC1 2

lOu mole./ml.

S u moles/ml.

KCt

70 u mol•• /ml.

40 u moles/ml.

Thioethanolamine
ATP

PEP

S u mole./ml.

0.5

U

lIole8/.1.

(79 }

...---_.

...-----

KEJ.LlR

(it 7l

175 u moles/m1.

-----2 u moles/ml.

varia.ble
---_ ....

1.0 u moles/ml. 0.5 u mole/ml.

5 u mOles/ml.

10 u moles/ml.

lOu mOleslml.

Pyruvate kinase

25 u grams/ml.

30 u grams/ml.

30 u grams/ml.

GTP

0.25 u mole./ml. 0.25 u mole/ml. 0.2S u mole/ml.

KHC03

...... -_......

L-A1aino Acids

------

Isotope

2.220,000 dpm.

• ... ---0.05 u mOle/m1.
100,000 cpm.

17.5 U 1101•• /181.
-----82.000 cpm.
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It has been previously shown that the oral hypoglycemic
aaents affeet both the incorporation of leuC!lne .... C14 into protein
and the eatabolism of leueine-C 14 .a measured by 01402 evolution (22).
cataboli~

It was desired to eliminate the .ffects on leucine
so that th8 true effect on the incorporation of

18uc:ioe-014 into protein could be studied.

It was hypothe.ized

that this might be accomplished by incubating only cell .ap and
microsomes which would allow proteins to be synthesized, but
which might not contain the enzyme. necessary for the catabolism
of leucine.

The followlng experiment was

desi~ed

to test the

validity of this hypoth•• is.

Three normal rats were sacrificed and a
from the excised liver in the usual manner.

h~nog.nate

prepared

The nuclei and eell

debris were removed by centrifugation in the cold for 1.5 minute. at: 700 x g.

The supematant was divided into two part .. :

one portion was kept' refrigerated for ineubation; the other was

used to prepare microsom.. and cell sap as de.cribed in the
preceding chapter.
for two hours.

A s.rle. of flaaka was incubated at 37 0

o.

Each incubatiOft fl.sk contained the following

component. in • total volum. of 1.05 al.; 2.0 u mol•• ATP; 10

u mol•• creatiae phosphate; 0.4 u mol•• OTF; SO u 8ram. er.atine
phosphokinase; and 1.0 u curie Leuclne.C 14 •

The reaction was

initiated by tbe addition of one of the following:

whole

homogenate; microsomal suspension only; cell lap only; or
microsomal suspension plus cell sap.

c 1402 liberated ifl the

course of the incubati.on was trapped in KOH in a center well
and was later precipitated as BaC 14 03 •

The preeipitatewas

treated as previously described (21) and counted in a thin
window Gcd.soer-Mueller counter.

Th.e amount of radioactivity

present in the sar.tple was

to represent the degree of cat-

t~k.n

abolism of leucine that occurred.
in Table V.

The results are presented

The.e data indicate that no appreciable amoW\t of

leucine.a l4 is catabolized by either the microsomal or the

soluble fraceion of nomal rat liver.

Thus by incubatin6 a

microsomal system, the effects of the oral hypoglycemic agents
on the inco1:'poration of lGUcine-C14 into hepatie protein may be

stud1ed independently of their effects on leucl.l'le catabolism.

Since it was not germane to the problem. the intracellular a1te
of leucine catabolism

WI

not investigated further. but it 1;.,1OUld

be reasonable to assume that it 18 found 1n the mitoehondrla.
Since 1t was decided that it would be advantageous to

study leucine-C 14 incorporation into protein in a microsomal
syatem . . . . . of the par.eters of such a .,.stem bad to be
clarified..

The following seri •• of experiments waa

d~.i&D.d

achieVe optlmal condi.tions for meaaur1ng prote1n synthesis.

all of the experi.menta were run 1n the order given
rather .aconditions directed.

bere~

to
Not

but

They are pres.nted. therefore.

1n a 10aiea1 rather than cbronological order on the followlns

TAILE
IILIbiI 9[

Y

flQ1 WCll!jt-C 14 §X
!MlOUS '1&£1:1911 or MQBMAL RAt LIID
C142e

Count. per Mlnute of C14

•• lac 1402

Fracel_

TRIAL I

TRIAL 11

I

....

12,749

23.107

Xicrosanes only

400

622

Cell sap only

120

141

601

783

lh,'ho1. hooogena'te

l>11 eros Que 5 plus

..

call sap

.Nt I

Each value repre.ents the mean of 3 flasks.

...

• *
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1D12 fltpat,s frps'Ln·

Incubations were run in trip11cat. at 31

o

C. for two hours.

Each flask contained In a total volume of 1.20 m1.:

2 u mo1.s

ATP, 10 u mol•• creatine phosphat.; 0.4 u mol., GTP; SO u grams
creatine pho'phoklna,e; and the uaual quantity of microsomes
and cell sap.

The amount of L_leuclne_C 14 was varled betwe.n

0.5 and 2.0 u curies per flask.

The ,eactlon was termiraated

and the protein isolated and counted as prevlous1y described.
The re.ults are ladleated sraphically in Fllure 111.
l t is apparent fr_ this graph that the amOW'lt of incorporation is a lin..r lunetie with respect to the isotope CODaentration ow, the ranSe studied.

It has been reported in the

literature that upon the addition of 1ncr... ina concentrations
of a radioactive amlno acid to a cell-free system, a saturation
1.... 1 18 reached after which there ls no further increa.e ln
incorporation regardless of the isotope concentration (119).
Obviously, in the pre.ent experiment. this level bas not been
attained and it would be econoalcally unfeaslble to run future
ex,.ri.r:,~nt.

re&4cr,j

:'H

at sucb a Mlh concentration of lsotope.
arbitrary cholce of 1.0

1.1

For thls

curie was .elected for: the

isotope concentration; thl. deaislon r.pr....ted a reasonable
compromis. b.tween the conflicting factors of maxtmal lncorpor-

3000

2000
~

a.:
u

1000

o

0.5
fL

I. 0

CURIES

'iaur.

I. 5

2.0

ISOTOPE

III

The Effect of Isotope Concentration Upon tbe
Incorporation of Leucine....C14 lnto Hepatic Prote1n

ation and expen.e.

It might be wall to mention the manner in which the incorporation data are expres ••d.

All data were calculated first

a. counts per minute. then .a counts/min./ag protein based on
both the dry weight of the protein and on the biuret reaction
of Gornall (33).

As the experiments pro&r••• 8<1. it became

inerea.insly evident that the reproduce.bl11ty of the observatlons was consistently greater if the actlvity were expressed
8imply in terms of counts per m1nute (rather than .. s counts per
minute per mg protein).

Thi. ob.ervation was interpreted to

mean that the error inherent 1ft m. .surin, the 1'rot8ift concentration was Ir. .ter than the error involved in the various
man1pulations of the expertment.

For thi. reason, all data are

expressed simply in terms of count. per minute.

IDttIMnS! 1.B4!: 1M I'f_' .11 goac'si lbSsPlliSI ; . .,,SEtSj.. YES l1lI InsUROfatlgn Sf. LtuSLlt:g14 !!l!.2 titDltj.S

lrot'Y.
Each incubation flask GOfttatned the followins oofactor. in
a total volume of 1.0S ml.:

2 u moles ATP; 0.4 u mole

aTr,

SO

u &rams creatine phosphok.ina.,; 1.0 u euri, l.euc1ne-C14 ; and

the usual quantity of microsom,. and cell sap.

The concentration

of creatine phosphate was varied between 0 and 100 u mol...

The

result. of the., experi.ents are presented 11'1 'laure I V.
The two .eparate experLments were run on different days and

.58 ...
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Figure IV

The Effect of Creatine Phosphate Concentration upon

tbe Incorporation of Leucine-C14 into protein.

(Two

••paE'ate ExpeJ:'iJaent. are depieted in the diagram.)

each point was detemined in dup1le8t..

It 1s apparent from

the sraphe that maximum incorporation occured at a creatine

phosphate concentration of 30 u mol.s/ml.

The inhibitory .ffect

of higher concentrations has not beem previously reported, and

may simply be due to sodium ion effects or increased ionic
Future experiments, then, were performed using this

strength.

optimal coneentration of creatine phosphate as the storase form
of ATP.

ill?rW95

1: .IJlsl

i(f,st

.u. AIl. !t2DnptEISi.!D l!I!!1 sat.

Ipqg[p2r!t~2D st k!YSlgt.c14 1n1! HIR'S'c Pt9Se~n.
'rhe experuuantal proeedure was the... aa previously des-

cribed.

Each flask contained the followioa cofactor. 1n a

total volume of 1.05 ml.:

30 u mol•• creatine phosphate; 0.4

u mol •• GTP; 50 u &r. .s creatine pbosphokina.e, and 1 .. 0 u curie

of leucine-C14 •

o and

The concentration of ATP was varied between

10 u mol•• /ml.

The results are illustrated in Figure V.

Max1mal incorporation of leucin••C14 into protein is

achieved at an ATP sone.ntration of 2 u moles/ml. with a very
pronounced inhibition of incorporation at hi&ber concentrations.
This inhibition by exce.s ATP ia the reason why an ATP generating syst_ (e.g. creatine phosphate-creatine phosphokinase)
must be supplied to the media.

It is unlikely tbat the mechan-

ism of the ATP-1ndueed inhibition ia solely concerned with

campiexing Mg++. since the Mg++ concentration is 1 u mol.a/flask

4000
•

~ 3000

a.:
u

2000

1000

o

2

A.T.P.

4

6

8

fLMOLES/ML.
Fi.gure V

The Effect of A.T.P. Concentration upon the Incorporation ·of Leucine-C 14 into Hepatic Protein.

10

while the inhibition by ATP ia evident at an ATl concentration
a8 low .1 3 u moles/flask.

£: Ill! Effe£t .21 f\~f ConSel'l.tr..tttion ~qn !11.!.
Ins2Eeorat&oD s! L!HSlne-C 14 ~ H!2 ilt tS f£9 te l n •

Exnr!aent

The experimental procedure was the same a8 in the previOUS
experiment.s.

Three conoentrations of GTP were used:

0.0, 0.5.

and 1.0 u moles/mI •• each point being determined in triplicate.
Tbe results are presented in Table VI.
Tbe

data

8\''lf£,i;eat that the

pres..nee of exogenous GfF has

little or no ('!ffect on tho incorporation of leucine-c14 intr)
prote1n.

This conclusion is in direct conflict with numerous

reports in the literature (41) (85).

However. it is quite

U . kely that in the present case there was sufficient endosenous

GDP and GTP ava1.lab le in the 11ver homogenate to make the
addition of further OfP superfluous.
by

This view is strength.ened

the observations of Schmits 8t ale (92) that there 1s a

conaiderable amount of GOP and OTP pre.ent in normal rat liver.
Howe....r.

since there might be individual differenee. in the

amount of endogenous suanine nucleotid•• in the livers ef
different rat., it was decided to add 0.4 u male. af OTP to

each incubation fla.k in the future to en lure that this would
net be a llJlltlng factor.

Secau•• 0.4 u mol•• of GT!" dld not

inhibit the ineorporatinl proce •• , 1t was ftzlt that no harm
could be done by thi. procedure.
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'fABLE VI

, BC9lPOIATI2l!

or

,rI', S;ONCPTMIlg!

'EWit
t.._LEU!I&NI_SC 14 IMI2 HEPATl~ flO'Eilfi

IHliflEQI OF

U,ON

OTP Coneefttratlon

Count. per Minute

u mol••/ml.

0.0

2151

0.0

2174

0.0

2242

o.s

2288

0.5

2381

o.s

2370

1.0

1969

1.0

2231

1.0

1994
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Iml0 tpo£ation 2t. i..·nc lP._g14

.i!l1.2 h'2at i:sfE2:Fti a.

The procedure was exactly the aame as m,ntioned previously,
except that the concentration of the enzyme was now varied

between 0 and 400 u grams/mi.

The results as shown in Figure

VI t.ndicat. that tb. presence of .xog.nous oreatin. phosphOk.inas. greatly stimulates the incorporation of leucine.. C14 into

bepatic prot.in.

The degree of st1aulation is ind'p8ndentof

the amount of enzyme added over the concentration rang. studied.
indicating th.:':rt as little as 20 u grams of enzyme i8 adequate

for maximal incorporation.

Future uperiM.nts were performed

using 50 u grams of enzyme per incubation flask because of the
difficulty lnvolved ln accurat.ly walehin! smaller amounts and

beeaus. the cost of the enzyme was not a limiting factor.

.I.1l2 Etf!st 9.! t1t. Cb:0s9!l1 £~,r!!;ent"ati;qn Y2.5m. .ttl!
14
ID94.lIRorat1o,D .2f. keusine-g .mt.2 Hsmat1 2 .f.Eot!in.

buNeDt!:

For this experiment, the microsomes were prepared as usual

and suspended in buffer so that the microsomes from one gram of
liver would be eontalned in a volume of 0.4 ml. of suspension.
Aliquot. of this suspension ware further diluted with bufter to

contain the mierosomes from 0.5 gratfts of liver and 0.2S grams
of liver.

The reactions were initiated by the addition of 0.4

ml. of the appropriate microsomal euspension and the incubation

was run for two hours at 37 0 C.

the cofactor coneentr.clOD was
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the s.e as in the previous experiment.
Figure VII indicates that the incorporation of isotope
into protein is proportional to the concentration of microsomes
added.

This proportionality appears to be leveling off at the

higher concentration of microsomes, but is not yet independent
of the microsome concentration.

Presumably, if the concentration

were increased further, a saturation level would result in which
the further addition of microsomes would result in no further
increase in incorporation.

It is, however, not feasible to work.

at a higber concentration of mierosomes because of the larse
number of anima ls which would be required f or each experiment.
Thus all experiments were run using the mierosomes from one
gram of rat liver.

.2. and lQ:

Exneriments

Tbe Et,ess s! ll!!!. .2f. Incu);uaSiop

U.ROft

!h!. ID90reoEatlon !l! Legsye-c14 ~ H!eaSiS lEOS,lUe
The incorporation of leucine into the protein of rat liver
microsomes was studied as a function of the incubation time.
The concentration of cofaetors was the same as that previously
employed, and each incubation flask received the microsomes
from one gram of normal rat U. ver.

The results are shown in

Figurel1Il.
Trial

1

was started s:lmply by the addition of microsome.

to the reaction flasks; all other components had been previously added.

Since the isotope and the eell sap were present

tosather for 30 - 45 minute.

it was

o.stble that formation
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(The microsomes obtained fram

0.25, 0.50, and 1.0 grams ot liver ware used for the experi.ental
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(Differenc.. in

Exper1.m.ental procedure between Trial 1 and Trial 2

are discussed in the text.)

-63of the sRNA-AA complex had already occurred before the incubation was run.

If this were a slow step in the protein

biosynthetic process. then tbe time curve obtained would be
artifactual.

Accordingly. a separate experiment (designated

as Trial 2) was performect. in wtli.. eh the incubation was started
by the si.multafteous addition of both mierosomes and cell sap.

t t is apparent from the graph that the time course of incorporation is qualitatively the same in both eases.

This might

be taken to indicate that the first two steps in protein
biosynthesis (i.e. amino acid activation and transfer of the
amino acid to sRNA) are not rate limiting in this system.
The very rapid patterft of incorporation indicates that the
reaction is certainly complete after thirty minutes incubation
t1m.e. and that it is not necessary to incubate for two hours
as has previously been done.

Nevertheless. the longer incuba-

tion period does not result in any lowering of activity. indicating that catabolism of the protein i8 not a factor.

All

of the succeeding experiments were run on the level portion of
the curve. many for the full two hours simply because it was a
convenient lensth of time.
It should also be noted frem these experiments that the
absolute levela of incorporation vary widely from day to day.
This has invariably been found to be the case. and is probably
the result of many factors.

Such variable • • s the age. health,

and heredity ot the animals would be expected to influence the

-69degree of amino acid incorpora.tion.
il

Similarly. there exists

large number of experimental procedures which differ alightly

from day to day and certainly have a bearing on this problem.
The speed with which the liver is exeized from the animal cannot
be adequately controlled; the amount of time it takes to waigh
the livers

different.

w~y

vary; the temperature of the buffer might be

There are literally dozens of sueh. factors which

may shange the absGlute amount of incorporation from day to day.
Henee it is impossible to compare experiments run on different
days, except in a qualitative sense.

ll.= .I.b2 Effest .2! Ii.ms .2! fEe-Inglbat1.og Ueen 1ht.
1nC2IPo,at1.on .2f. LeuSln$-sc 14 .ir.n£2 HlB!tic fateln.

EJp!ryegt

The 'very short time required for maximal incorporation as

seen in the previOUS experiments sould be due to a number of

fastors.

It might be that some substance needed for the re-

action is limiting; it mi&h.t be that the incubation temperature
inactivates the enzymes or RNA; or it milht be a oombination of
the.e effeets.

This exper1Jnent was de.ianedto test whether

the incubation temperature had an adverse effect on the ineorporatill! system.

Mierosome. and eell sap were isolated from

the

li~·.rs

of normal rat. and were pre-incubated togetber at

37°

c.

varying periods of tl.me. aliquots were withdrawn and

to\.t

used to start the actual incubation by addition to flasks containing the cofactors and isotope.

The incubation was then

... 70allowed to proceed for one hour before being terminated by the
addition of 10% trichloracetic acid.
The results in Figure IX indicate that there is, indeed,
a heat labile factor present in the mixture which is adversely
affected by the 37 0 C. temperature of the ineuhation bath.

This

heat inactivation l')henomenon accounts for a large part of the
fact that incorporation of leuelne-C 14 into protein i8 virtually
complete after twenty minuteSt although it is not the only
contributing factor since the microsome. and cell sap still
reeal,n some activity after this period of tlme.

However, it

would be unprofitable to search for other factors, beeaus. the
time of active incorporation would always be limited by this
heat inactivation.
EIRex:!ment

ll: Ib!

ASlds .Y.n.2n ;the

.21 Sht 6dSi-ti gB s1 UU1al!,11.Id 6mHl!
lDsoJ\Poratiog .2f. l,eyga.tU,_,14 iDa H.paSic fEot.J.n.
Effeqt

Some investigators bave de. .ed it necessary to add a mixture of unlabeled amino acids to the protein synthesizing ayatem,
while others made no such addition, relying entirely on the

andoa.nous supply (ct. Table IV).

this experLment was designed

to determine Whether such an addition was necessary or useful.
Accordingly, a solution wes prepared conta1nin& 19 unlabeled
L-amino acids

(deta11~

are

~ivet"l tn

the Appendix).

Two simul-

taneous incubations ""Tilre run; one containing 0.043 u moles of
each L-amino aCid, and the other

eontalnln~

only the usual eom-
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Figure IX

The Effect of Pre-Incubation Tt.e Upon the Incorporation of Leucine.C l4 into Hepatic Protein.

30

-72pounds.

Flasks 1n eaeh group were incubated for varying periods

of time and the reaetion terminated in the usual manner.
Figure X shows a very slight enhaneement of incorporation
in the ea.e of the flasks which eontained the added amino acid
mixture.

This was not considered significant enough to warrant

eontinued use of the unlabeled amino acids except in the cas.s
where .in %!.x2 experiments were performed.

Th... wi 11 be

d.scribed later in the chapter .s they arise.
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(clo••d circle.- no exo-

genous amino acids added; open cirele. - mixture of
19 unlabeled amino acids add.ed to each flask.)
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EFFECTS OF THE

l!

VITRO ADDITION OF TUE ORAL

HYPOGLYCEMIC AGENTS ON THE INCORPORATION OF LEUCl1:U:C14 INTO HEPATIC PROTEIN
EI2e,1m'n~

ll:

Eft'st!!1 the Con9,01:£atioo !!1 Three O,.l

Hro9g1ycemie Agent.
HeRfS!s

sm. 1b Inso£J?q[ation .21 L,uelne-C 14

in~o

ProS,in .2t Nomal Rat ••

Ten female rats were sacrificed and a microsomal suspension
prepared from their livers in the u.ual manner.

The microsomes

and cell sap were incubated at 37 0 C for two hours with the
optimal concentration of cofactor. as determined in the previous
experiments_

No unlabeled amino acid mixture was added to the

incubation flask. in this experiment.

A known amount (0 - lOu

moles) of one of three oral hypoglycemic .,ent. (tolbutamide,
chlorpropamide, or phenethylbiguanide) was added to each flask.
To ensure that any effects observed were not due simply to an
increa.e in ionic .trength. control flasks containina similar
amounts of sodium chlorid. were incubated simultaneously.

The

reactions were terminated and the protein isolated and counted
a. previously de.cribed.

The result. are depicted in Figure Xl.

It is apparent from this diagram that all thr.e agents inhibit the incorporation of leucine.C 14 into the liver micro-

lomes of nomal rats to approximately the same extent.

Further.

the degree of inhibition is directly proportional to the
concentration of agent in all ca.e., amounting to approximately
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Figure XI

The Etfeet of thft !n

Addition of Various Compounds on the lneorporation of Leuc:ine_C 14 into the
Vi~[2

Protein of Liver Mierosomes from Normal Rats.

60% inhibition at a concentration of hypoglycemic a3ant of 10

millimolar.

The data obtained for sodiUll1 chloride demonstrate

that this effect is not attributable to either an increased
ionie strength or an increase in the concentration of sodium
ions.
The behavior of phenethylbiguanide in this system closely
parallels that of the other two 4&8nt8.

To verify the observa-

tion)the effect of pbenethylbiguanide concentration on the
incorporation of leucine_C 14 into protein was run a second time.
The data from this confirmatory expertment appear in the appendix as Figure XIII.

The linearity of inhibition with respect

to concentration of phenethylbiguanide is in contrast to its
reported effect (22) in a whole homogenate system (mitochondria
plus microsomes).

This difference is attributed to the fact

that leucine is not significantly catabolized in the microsomal
system, whereas a great deal of catabolism (relative to the
amount of incorporation into protein) occurs in the whole
homogenate.

Since it was shown (22) that phenethylbiguanide

has a relatively large inhibitory effect on this catabolism.
it now appears that the unusual behavior of phenethylbiguanide
in inhibiting protein synthesis in the

~hole

homogenate is

really secondary to its effeet on leucine catabolism.

Once the

two effeets are separated, .s in the present experiment, 1t
appears .s though phenethylbiguanlde acts in much the same
manner as tolbutamide.

.. 77 ..
Experirl1ent

.!l!=_ The

E{tect

.2! LOWtr Concentrati.ons 9l. the

Qal !U!poglyeEiS Aau!fJtp !lS. .£h!! IncQrporation if Ltycine-C 14

inso

H$Qa'E~S

ProStia

!11~omal

Rats,

Although the previous experiments demonstrated that certain
concentrations (0 - 10 millimolar) of the oral hypoglycemic
agents inhibit protein eynth•• is, this does not exclude the
possibility that other lower concentrations might have exactly
the opposite .ffect.

For this rea.on it was de.ed .xpeelS.ent

to ascertain the effects, if any, of the

1D.

n;Eo addition of

lower amounts of the oral hypo&lyeemic agents on hepatic protein
synthesis.
Duncan and Clark (26) report that the blood level of
arylaulfonylurea required to elicit a hypoglycemic response
~~

!ivo equals 10 - 15

mg~.

Simple calculation demonstrates

that this is equal to 0.31 - 0.51 millimolar, implying that the
concentrations used in the previous experiment were considerably above the "physiological" blood concentration.

Similarly,

they report that the blood level of phenethylbiguanide required
for a hypoglycemic response is only 5 ug/ml. corresponding to

0.021 u moles/ml.

This would seem to imply that a totally

unrealistic amount of PEB3 was used in the previous experiment,
except that \';iok .It 411. (Ill) have reported that thia compound
is grea.tly concentrated in the liver upon injection, so that we
would expect a hepatic concentration of phenethylbiguanide to
be considerably above the circulating blood concentration.

-78This incubation was performed in the same manner as the
previous one.

Four seta of flasks were incubated in triplicate

containing respectively:

no addition (control); 12.5 mg%

tolbutamide; 12.5 ma'%. chlorpropamide; and 0.5 mg% phenethyl.
biguanide.
The results in Table VII indicate that these lower concentrations of hypoglycemic agents have no appreciable effect on
the incorporation of leucine.C 14 into hepatic protein of normal
rata.

It is posaible that a slight inhibition is seen in the

eaae of chlorpropamide and phenethylbiguanide, but the aisnificanee of this is doubtful.

At any rate, it is certain that

this lower concentration of the agents does not stimulate
protein synthesia as might be desired for these anti-diabetic
compounds.
EI1?riment

ll:

Effect!l! l.bI eggsentration .21 Three Oral

Hnol1rgtmj.C Agegt.
aePltts PEosej.n

s1

sn lb!

Incorpor.tl:gn 5!f. Leusine-C14 i.n£2

All0J!n-pj.ab,tJ,s RaS.,

Twelve female rats were made diabetic by the injection of
alloxan as described in the preceding chapter.

Two days after

the injection, the animals were sacrificed and the microsomes
isolated fram their livers in the usual way.

The blood glucose

levels of the animals at the time of death were all above
500 mg.,. as described in the Appendix in Table XXV.

An incubation was performed exactly as in Experiment 13

-79TABLE VII

IHE EFFICT OF IH§ IN

VITRO ADDITION Of A LOW CONgEN-

TRATION OF THREjE ORAl: HXPOOLXCPUC AQQ!TS ON

IdE

INCORPORATION OF LEUCINE-C 14 INTO JijiPA'tIC rROTE\N
OF NOR.M:t\L EtATS •

Incubation Conditions

C.P.H. in Hepatie Protein

Control

1704

Control

1802

Control

1855

Tolbutamide 12.5 mg%

1742

Tolbutamide 12.5 m8%

1742

Tolbutamide 12.5 1081.

185.5

Chlorpropamide 12.5 ms%

1543

ma~

1534

Chlorpl'opamide 12.5 109"

1672

P.E.B.G, O.CS m@,%

1650

P.E.B.G. 0.5 mg""

1727

P.E.B.G. 0.5 mg'%.

1653

Chlorpropamide 12.5
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where the concentration of hypoglycemic agent was varied between

o and

10 millimolar.

Again, controls were incubated simul-

taneously in which corresponding amounts of sodium chloride
were added.
Figure XII illustrate. the reaults of this experiment.

It

should first be noted that the absolute level of incorporation
of leue1.ne-C14 into the H.ver microsomes of these diabetic
animals is very much lower (by a factor of 10) than the level
of incorporation found previously (Experiment 13) employing
liver mierosomes from normal rats.

When normal rat liver was

EHDployed t the incorporation into protein was above 4000 cpm at
zero concentration of agent; in the present ease it is only
about 400 epm.

This observation supports those of Robinson (91)

and Korner (50) which were discussed in Chapter II.
Further examination of th.se data is not especially fruitful, in that it ia difficult to ascertain whether the

in ViS EO

addition of the agents bas an effect on protein synthesis in
this case.

It appears aa if tOlbutamide and chlorpropamide

exert some inhibition And that phenethylbiguanide does not.
The difficulty arise. from the fact that the incorporation of
leucine into protein ia so depressed by the diabetic state
itself. that it is extremely difficult to demonstrate further
depression by the in yitEo addition of the oral hypoglycemic
agents.

For this reason, further experiments utilized the liver.

of noma 1 anima ls.
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The Effect of the

In Vit£o Addition of Various Compounds

14
on the Inenrporation of Leueine-C
into the Protein
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t;xperiment

ll.:

~

Effect

.2! !.!!2 £m1

Hypo~,llcemle

the 1.ftso[J?o!,4tion ~f Leu,eine-:C:4 • 1,ysine.. c14 t

cl~tnto Hepatic Pro~elq

£1

Asents ,gn

!Z!.9. ~h!nxlalanin!

Norm,l Rats s

Although Experiment 13 demonstrated that tolbutamide,
chlorpropamide. and phenethylbiguanide added in y1tro inhibited
the incorporation of leueine-C 14 into the liver microsomes of
normal rats, it was not certain whether this was a a;.eneral effect
on protein synthesis or one peculiar to leucine alone.

Aecord-

ina1y, an experi.ment was deviaed to test the effect of the oral

hypoglycemic asents on the incorporation of three different
isotopes into the hepatie protein of normal rats.

The hypo-

glycemic agents tlsed in this experiment, and in most subsequent
experiments, were tolbutamide and phenethylblguanide.

Chlor-

propamide was omitted beeause of its aim1larity to tolbutamide
1n both structure and proposed mechanism of action.

It was felt

that tolbutamide and pherutthylbiguan1.de would adequately repre-

.ent the two major elasses of hypoglyc_ic compounds (i.e. the
arylsulfanylureas and the guanidine derivatives), and that little
would be gained by including chlorpropamide in the study.
The th.cee isotope. used in this experiment were especially

desitned for incorporation studies by Schwarz Bioreseareh Inc.
(Orangebur!;,. New York, 10962).

Each amino acid was supplied

as the hydrochloride and each had the same specific activity
(SO u curi.s/u mole).

They were dissolved in doubly distilled

water. and 1.25 u curi.s of the proper isotope was added to

.83each incubation flask • .along 'tJi tn the usual amount of premix.
To some flasks in each isotope

~roup ~r0 ~dded

tOlbutamide and

phenethylblguanide to e final concentration of 10 millimolar.

The incubation ,vas

besun by

the addition of microsomes and cell

sap and terminated afteE' 2 bours in tbe usual manner.
The results •••n in Tabl. VIII 1ncU.cate that both. tolbu-

tamide and pnenethylbiguanide inhibit the incorporation of all
three isotopes into protein.

thus it appears that this effect

is &eneral and not specific for a si.ngle amino acid.
These data also vi.ndicate the original choice of leucine-

C14 as the isotope to be used.

It ia seen fE'en the table that

the control incorporation of leucine.C I4 into protein is more
tMll twice that of lysine_C14 and

some~. hAt bisher than

pb.enylalanin••C14 •

EIP![W.nta

II .!95!!!: Ill! Eff!SS .2! l'ol!mtam&d,

and

bimlan\de .!m the Inqo£20rl!&0ft s.t Lwclnt.c14 .1.DS.2
M\q;os9I!11y-bound

PEote1g

st

NO'lll I!£

fb,n'tbr 1-

SolY1!le !.!1d.

L~YlE.

Whether the oral hypoglycemic aaants inbibited both the
101uble and rnicrollomal-bound protein. or only one of th••••

was lnvestisatad.

Previous experLments were concerned only

with th• •ffect of th.se compounds On total TeA precipitatable
prot.in i.e. both soluble and m1crolOll'1al-bound protein taken

tog.ther.
Accordingly. incubations were peE'formed .a usual in the

TABtE VI!l
THE,EP':ICT OF. ,THI 1.1 .!lTRO,,:<\.q-qITIO~ OF ~Q~BUTA!1lD.~

!,:ffiJ .Pliit!ETHXLBlGUANIOI Of! lID; INCORfORATI 0 lf OF

LY§iIN~"Ql.~. AN)2 .PJR:"ILALANlt'E...C!4
H~P~TIC '?'''9.!ttN 2r N.Q,!MAJ:o rt~1s",

tIgICIlttE_c14 I
Ttm

.

• Ii!"

,

.

..... . ..-

. _.11

INTO

.. .

I nC'llba t'1 on

l.. eueine

Lysi.ne

Phenylalanine

Condi-eions

C.P .. M.

C.P .. M.

C.P.M •

•

Control

3420

1336

2648

Control

3371

1252

2329

TOlbutamide

1452

61.5

1741

Tolbutamide

1367

604

1838

PEBG

1918

852

1503

PEBG

1900

669

1572

-8S ...
pre.ence and absence of two oral hypoglycemic agents.

At the

end of the two hour period, the reactions were stopped by the
addition of 2.0 ml. of cold 1% L-I:eucine to each flask, followed
by chilling of the flaska in an ic....wat.r bath.

This .erved

both to slow dO'Wft the enzymic reaction and to dilute the
isotope with a large .xeess of non-radioactive leuCine, so that
any further incorporation would utilize the amino acid which
was not labeled.
The contents of each fl ••k were transferred to an ultr....
centrifuge tube (operation performed in the cold) by means of
three .liquots (2.0 ml. each) of ice-cold buffer Solution.

All

tub•• ware centrifuged .t 40,000 rpm for one hour to sediment
the microsomes.

At the end of this time. the clear supernatant

was decanted into centrifuse tubes and the pellet rinsed once
witb 1.0 IIll of buffer.

This rin.e wal added to the supernatant

and the total was taken to represent the soluble protein.

Sim-

ilarly, the microsomal pellets were transferred to centrifuge
tube. by means of 6 aliquots (1 ml. eaCh) of cold buffer solution.

Protein was precipitated in all tubes by the addition

of trichloracetic acid to a fin.l concentration of 5%.

The

precipitates ware then washed and counted in the usual way.
Table IX shows the results of such .1'1 experiment where the
concentration of hypoa.lycamic .gent was 6 mK.

From tbe mag.

nitude. of the control inoorporations it is evident that
rel.tively little soluble protein il relea.ed by the miorosome.

in tne course of the incubation.

This is somewhat surprising

in view of the fact that the earlier time-course studies showed
the incorporation of isotope into protein to be essentially
complete within 10 - 15 minutes.

However, the data do indicate

that the addition of the oral hypoglycemic agents causes a decrease in the amount of leucine-C 14 incorporated into this
soluble protein.
The data are not nearly as clear with respect to the effect

of thes. agents on the microsomal-bound protein.

It appears as

though tolbutanlide causes some inhibition whereas phenethylbiguanide does not.

In order to cL:,rify the picture, the aam.

experiment was performed a second time with a higher (20 mM)
concentration of a&ent.
The results of this second experiment are unequivocal.
Both tolbutamide and phenetbylbiguanide inhibit the incorporation
of leucine-C14 into soluble and microsomal-bound protein.

The

inhibition seen in the soluble protein is of apprOXimately the
same order of magnitude as that seen in the microsomal protein.
These data eliminate the release step of the protein from the
ribosome as a possible site of aetion for either of the.e agents.
If the,. blocked the release of the finished protein there would
be a large inhibition seen in the .oluble protein and little or
none in the microsomal fraction.

Since this was not the oase.

we can conclude that neither agent acts by inhibiting the release of the completed protein from the ribosome.
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TABLE IX

Xlii E;ftr;CI 01 lHl IN VITRO ADDlI1S& Of 'EOLBUTAl'11DE
AND PHENE'l,aXLllGIk\NlDE Od lUi Ifl90RPOMIIQN OF
LEUC1NI-C14 1NAQ SOLUBLE AND HICiQS~L-19U£lDPB.QIilN,

Incubation

Soluble

Microsomal

Conditions

Protei.n
C.P.M.

Protein

e.p.M.

Control

236

1637

Control

226

1616

Control

223

1580

Tolbutamide 6 mM

166

1297

Tolbutamide 6 mM

178

1351

Tolbutamide 6 mM

174

1269

PEIG 6 DIM

175

1592

PEBG 6 mH

170

1484

rEBG 6 mM

169

1575

-88ill?!fiLmsn t li

l2.

and AQ:

but_ide IpMbi$igp.

The

l!l

!.i~f9 ~

!2! Actiog !If.

~he

Iol-

!d.. l!aRa;!' PE9t1in Sygtgelis.

'rhese experiments. designed t (') loea liz8 th.e 81 teof inhibi-

tion by tolbutamide. utilized a
from previous incubations.

some~~at

different procedure

In each exper'l.ment. the eel1 sap was

pre-incubated with the isotope and premix tor 10 minutes.

Th.

experimental variable. fell iato three groups;
1)3 flasks contained only cell sap and isotope; after 10
minutes pre-incubation the reaction (prot.in synthesis)
was be&un by the addt. tim of microsomes.

These served

as controls.
2)

3 flasks contained eell sap, isotope. and 6 u Moles

tolbutamide durin& the pre-incubation; the reaction was
initiated by the addition of microsomes.
3)

3 flasks contained only eell sap and isotope during

the pre-incubation; reaetion was initiated 'by the
simultaneous addition of 6 u moles tolbutamide and
microsome••
The rational of the procedure ts as fOllows:

During the pre-

incubAtion procedure. the reaeti01'ls which occur in the eell sap
alone can take place i.e. the first two steps leading to the
formation of tne s - RNA ... l\A aomplex.

If tolbutamide inhibits

one of these steps. ies presence during the pre-incubation
should result in an inhibition 'but if it ia added with the
microsome., no inhibition 'Would occur beeause tbe first two

TABLE X

IHI RlEQI Or 1111 IN tlDO APRIIl91 Qr Jl~LBJlTN1'DI
AND PH§NrtHnllQYA!lRI OJ! IHI ll!WRPOMilgn. 21
Li!lg'NE.Ql~ lNIO S9LUBLI W tll£ROfSJJ6L-IQYND PJ.9'IIIN.

Incubation

Soluble

Mlcros. . l

Conditions

ProteiD

Proteln

C.P.l'l.

C.P.~i •

Control

.590

89.55

Control

566

8824

Control

581

8929

follNe_ide 20 mM

136

1869

Tolbutamide 20 111M

144

2038

Tolbutamide 20 RIM

134

1976

PEIG 20

aM

209

1763

PEBO 20 RI

161

1686

PEIG 20 111M

146

1727

-90.
reactions have already taken place.

The data from two such

experiments are presented in Table Xl.
It is apparent at first glance that the incorporation of

leucine-C 14 into protein is lower than that usually obtained
even in the control flasks.

This is in agreement with the re-

sults obtained in Experiment 11 which showed that pre-incubation
lowered the incorporation of isotope into protein, probably by

denaturin& some heat-labile factor.
In order to clearly see the results of this experiment and
the conclusions derived therefrom, it is necessary to summarize
the data in Table XI and to briefly outline the steps involved
in the classical scheme of protein biosynthesis.
Summary of Oa till
Experiment 19
Av. C.P.M.

Oescription

experiment 20
Av. C.P.M.

Control

908

1422

Cell Sap + Tolbutamide

683

904

Microsome. + Tolbutamide

622

908

I.
II.
Ill.

Amino Acid Acti vaticm
T~an.ter

ot Amlno Acid to .-INA

Arrangement of Amino Acyl-RNA'. on Template

IV.

Formation of P.ptid. Bond.

v.

a.l.... of Soluble Protein

TABLE Xl

lUI 1" !lIIO SITE
9f HlPAII~

fRatl1!

or AQ,tl2t!

9l iOLlUIAMlRl IIHII1IIQl!

SXNtHIIIS.

Incubation

C.P.M.

C.P.K.

89S

1453

1004

1391

82S

1422

710

879

durin8 pre..

694

901

incubation

645

932

As.nt added with

610

915

.icro..... .fter

646

917

pr•• 1.11CNbation

611

892

Condition.

Cont .... l:

no Tolbut-

amide added

A"ant

p.....t

The first two of the •• steps occur in the cell sap.

When the

cell .ap alone is incubated with leueine-C 14 (and premix) for
10 minute., the fir.t two reactions would b. expected to occur,

re.ulting in the formation of charged

If the inhibition

s-P~A.

oceured at step. I or II, it would be expected that no inhibition by tolbutamide would be found if the ag.nt were added
after the 10 minute pre-incubation.

Actually, however, the data

show that the incorporation was depr••••d by the same amount
whether the tolbutamide was added before or after the preincubation.

This leads to the conclusion that the inhibition by

tolbutamide oceurs at the micro.omal level (Samewhere in Steps

III - V).

However previous experiment. (17 and 18) bave de-

mon.trated that .tep V i. not likely to b. the site of action
of tolbutamide added in litro, leaving the events occuring about
the template as the probable .ite of action.

(This also in-

clude.; of course, the po •• ibility that tolbutamide affects the
template itself, by interfering with the formation of m-RNA, by
cau.ing disaggregation of the polyribo.omes .tc.)
E!per!ment

Ii: Ib! la

mid. Inhib1£ion

~

Vi£Eo

J!1! Rt

AS£ion

at lb!

ChlorproQ!-

ijep!tic P£ot,&n Sygth•• t ••

The procedure and reasonina involved in this experiment
are preCisely the same as employed in the preceding one.

The

only differenc.s lie in the substitution of chlorpropamide for
tolbutamide and the u •• of a larger quantity (2 u euriefl) of

-93-

isotope per

in~lbation

flask.

The increasec isotope concentra-

tion w,s desitned to increase the incorporation at all levels

so that the inhibitions observed 'l;V'ould be more pronounced.

The

results are presented in Table Xl!.

The incorporation of leueine-C14 into protein was considerably higher at 21.11 levels than before due to the increased

concentration of 1.sotope used.

the

Sil-me

wh~ther

But the results are qualitatively

as with tolbutamide in that it makes no difference
the chlorpropa,mide is added before or after the pre-

incuba;tion period.

In other 'IJOrds, the site of action of

chlorpropamide is the same as that of tolbutamide. in so far as
this experiment can determine.

8ecause of the structural

Similarity of the two compounds, this 1s not a particularly
surprising faet.

i3Sperimtnt!

.u g

12: Tbl l!1 YUriro !J.£! !l!

fhtn,tbYlbiaupnlde Igb1blSigg !l!

H!R'~ls

A9~12n

Sl1

the

P£oS,ln S!Dth'l&s!

For these experiments, 1.0 u curie of l.uein.-C 14 was
employed; the procedure was the same as previously described.
Oatfl\

are

~iivel"l

in Table XIII.

AlthO'l.1,;)h the inh1.bition obs l::,ved in these experiments is

not very sizeable (due in part, at leaet, to the low levels of

inc:orporcStion achieved), the pattern is relatively clear.

all cases an

i:'libition 1.s

obs~rv.d

In

in the flasks containing

phenethylbisuanide, and it apparently does not matter whether

tABLE XII

ltiE

§lI'

IN XIIRO

HlllXlON

Of

Of ActION Of: 1m; ¥tYtOIlROrAMID! IN-

ljIfAI1C PRQIEIf SYNtHE§I§

Incubation

C"P.M ..

Conci iti OilS
t

Control:

ftO

Chlorpropud.de
added

4043
4280
3846

Ag_t pre.eat

2683

durin@, pre-

2.698

incubation

272.7

A&en~

added

2415

with microsomes

2534

after pre-incubation

2451

' ••

'l'AB~E

Iae

iN V~rRO

Sl"ri

Of ACTION

XIII

Of THE

pm.mtIll:a.B'QLJA~'D~

IN1J.I8r~lOI~ OF HQPt'\IIC ?ROIElN ~YNl'fiiSlS

In

£xperuutnt 22

lncubation
Condltito1D8

Experiment 23

C.P.M.

C.P.M.

Control: no

1429

1351

PheDethylblguanlde

1252

1462

1298

1412

Alent present

1101

1192

durin& pr....

1094

1098

iDcubation

1024

1102

"sent added

909

981

-

••

added

wi tb microsG!.11es

after pre-incubation

1078
1049

1069

the c_pound is added before or after: the pre-incubation.
concluaion 1. the ....

al that

The

reacbed for tolbutamide and

chlorpropamide.
The last fiva experiments demonstrate that the inhibition
of incorporation of leucine-C t4 into hepatic protain is very
similar in site of action for three different nypo&lycesic
asents; to lbutamide, chlorpropamide, atld phenetby lbiguanide.

When added ia lit£9 •• 11 threa affect the biosyntbetic process
somewhere at the microsomal level before the completed protein
chain is released from the polyribosome.

1t is not .urpristns

to find that the two arylsullonylure•• bava a stmilar mechanism,
but it il unusual that the auanidine derivative (phenetbylbi.
luanide) al.o follO'w. the s.a cours., in view of the many other
differenc.s known between th.s. two cla •••• of compound. (21).
The effeet of th... two ela.... of .gents on protein synthesis

may be contrasted, for example, with their reported effects on
ehO'l.•• terol biosynthesis (19) (73).

Both the

and the guanidine derivative. inhibit the

.ryl.ulfonylur~&s

!! litro

biosynth~~is

of cholesterol, but' their respective sit •• of action are markedly different.

Yit£2

On the other hand, both group' inhibit the !J1

biosynthesis of protein

quite simi18r.

How~var,

~nd

their sites of Action are

it must be emphasized that

th~ ~xp.ri.

menta described do not prove tbet' the three compounds studied
have the lame meebanillll $f action. but rather they indicate that
all three aet at approximately the aame point (1.e. the

-97ribosomal le~l) in inhibitinl the incorporation of leucine.C 14
into hepatic protein

!D litER-

--

ErnCTS Of THE IN VIVO ADMINISTRATION OF THE ORAL

111.

HYPOOLYCEMIC AGENTS ON THE

1! !IDQ IMCORPOlAT10N

or LEUCINE-cl4 INTO HEPATIC PROTEIN
hR!IJ.us~1

Iff.S;.If..t. Iwl! LIE,a &9 j'SSi•

2ft .. 27:

.9t

Ie1Jwtgj,Qa . . !hi. 1D Vitro I D t9G!EaJj.m .It LeuS1D,·c14 ~
HIHI&S letS,h,
Tha experlm_ts up to this point have b.en concemed wtth
the

JB nlE9

addi'tiem of the oral hY'POg1yc_ic a,'Dts to a

c.ll-fr.. syst_.

ID ordar to d.t.rmln. wheth.r the lDh1biticm

of prot.iD synthesis which was observed mlght b. of significanc.
in more physiological circumstano.s. the followins s.rl.s of

exp.rim.nts was d •• llfted.
were injea'ted

1D Jtl!2.

Usln, Whi't. feaal. ra'ts. tbe 'g.nts

the 11 ver was .xclsact aft,r a period of

tim. and the incorporation of 1. .O'1ne.0 14 into liver protein

n;,o was

m•• sured.

JJ1

Such .xperlJaent8 are far .or. c_plex in

r.gari to 1nterpretation becau•• a numb.r of conflietina faotors
misht contribute to the final r.sult.

ror.xampl•• the inj.ction

of tolbutamide into aft ant.mal .t,ht b. expeeted to produce at
l . . st two antaaoni.tic r.sults:

the tolbutamide it •• lf would

inhibit the biosynthesis of prot.in .a discussed previously. and
the tolbutamide would act

Oft

the paner. . s of the ana.1 to stim-

ulat. the prOduction of insulin which ift turn would acc.l.rate
the biosynthesis of protein.

The D.t ,ff.ct obs.rved would de-

pend on wbich of the• • •ffects was of the larg.r . .,nitud••

-99Four f.al. rats weiahing approximately 1SO g. were employed
in each expert.mer":.

T1:iIO were injected intl'aperltoneally with

0.3S millimole. of tolbutamide dissolved in 0.5 m1. of distilled
water. and two were injected with an equal quantity of sodium
chloride.

The

an~als

were sacrificed after

2~

hours without

food and a separate hamosenate made from the liver of each
antmal.

The microsomes and cell sap were isolated and the protein

content of each suspension was measured and found to be very

neax.-ly equal.

Eight incubation flask. were run, utilizing tbe

microsOlR&l au.pen.1Ofts fram the four animals.

Terminal blood

sugars indicated that the serum glucos. levels of the tolbutamide-treated animals were an average of 44

of the control anunals.
the first

two

m&~

lower than thos.

Tabla XIV illustrates the x.-••ult. fram

such experiment ••

The da t& obtained 1n the..

experiments were not consistent

because of the wide variation in incorporation between different
animal. as reflected in the ditferenc.. in incorporation in the
oontrol &nLmals.

While the relative incorporation of one •• lln..

injected anbnal waa approximately 2300 c.p.m •• that of the other

was about 4100 c.p.m.

Such variation of controls pre.lude. the

possibility of drawing any definitive conclusion., althouth the
data might indiaate that an inhibition of protein synthesi. is

observed in the livers obtained trom the tolbutamide-injected
animals.

It was felt that the wide variation in the ability of the

TABLE XIV

I'FECT-9F INJECTION OF TOLBYIAMIDE ON THE IN VIllO

INeORPO~~I.ION OF LEUPINE..g14 INTO IilfATIC PRotEIN Of
NORMAL RATS (NQI IrlII§E

MI§;l.

Injection

Rat

Number

1

Experiment 24

Given

saline 0.35

lit

Kol••

Experiment 25

c.P .f1.

C.P.M.

23S5

1583

2362

1562

1

..

2

n

4110

..

2681

4170

3049

1012

1592

2

3

tolbutamide 0.35 m Mol••

3

"

1017

1563

4

H

2195

1421

2304

1494

4

..

-101in(U.v1dual ant.m.als to incorporate leucine-C

14

into. hepatic pro-

t.ln .lant be due to. differances in the genetic makeup .f tbe
aalmal..

In order to. control this varlable, litter-mate. were

_ployed and the . . . _parisi_C. were repeated twice.

The

re.ult. are presented 1ft Table XV.

The.. re.ults are IIlUch more c8l'lslstent than th••e obtained
f~

experiment. in Which I1tter-mste. were not used.

The com-

bined evt.dance of thes. four exper1raente SUU.sts 8troaaly that

a 81nsle acute do.e of t.lbut_id. (0."

m m.l•• ) deer..... the

oapacity .f the aniaal's liver to incorporate leucine-C14 1ato

hepatic proteiD 1a a eell.fr..

.y.t_.

Th1a impli.. t:bAt tbe

dlrect lnhibitlon of thl. amount .f t.lbutamld. is sreater tban
the 8tbNlatlon caused by the In.r.... ln ln8ulin secretion
brou&ht about by the c_pound.

The.e r.sults 81ant be compared

witb those o.f Recut and 'lscber who. reported (88) thAt tbe acute

lnjectlon of 20 ms tolbutamide/lOOs rat had no. slgnificant eftect
on tM lncorporatlon Gf slYCUUI_C 14 into. rat-llver .11ce. ,Wl

viCEo.

The dlft.raM between their re.ults and those rep.rted

here may lle t.n the tact that a larser inj.ction .S8.1 veil in
the •• exper1ments (.3' m mol•• per rat .. 70 mg/100 g).

ala. po•• lble that the .ffect 18 not ••en 10
only 1ft a cell-tree system.

llve~

It i .

.lia••• but

Thi. latter explanation. howewr.

..... by tar the 1... likely of the two.

TABLE XV

mlC;: 51l ,"JlCTIO! 91 t OLIutN11QI ON Tm; II ntBR
P!~TI9l! Ql !rAlSC'I.-C1 4 am iJRttllC r.BfBlll
9ll!OJt1Ata IAtI (wna HAm Y'lRl.

1

1
2

2

,
3
4
4

'a1iDe O.'S • Mole.

.
.
.

Tolbut..ld. 0.3S • Mol••
II

.

..

2504

2223

2381

2195

3191

2640

3131

2820

1724

863

1837

882

2141

966

2216

930

.103.
ilR';:iml!'!~!§.:

!tlllgrttrqpgldl
~

SCIHt!d..!. Sialll tar,! &D,.Rti&

s

st

lJlI la Iitrg lacgEP9raSlaD .if. Leus1.pe"y14

HteS's fro'!!!,
Tbe experimental procedure was the same in all reapects a.

that used in the previous experiments.
with either 0 .. 35

n'l

Each rat

we.

Moles of chlorpropamide or 0.35

saline and the livers vera excised and hCll1logenlsed
after the injectiens..

In

injected

Moles of

2y

hour.

Litter mat •• were employed in the

experiment ..
The results in Table XVI indicate that the

la

~

injection

of chlorpropamide in a single acute injection of 0.35 m Moles

acts to inhibit the

hepatic protein.

1n ]iSER incorporation of leucine... C14 into

This effect 1s muoh the same as that seen

following the injection of an equal dose of tolbutamide ..

iffu.l 91 !. Slasl! YEll ,n iuti. .It btDtSbyl...
JlillMN.41 .E .£be 18. YUn lDsU'urat , • .If. LtvsLn.... y14 J.IWl
D'MS&S frStb.
Ilmtllaa!!2.:

The procedure va. the

s._

.a used in

the precedlna exper-

la_t. except that each an"'al received a do.e of pheD.thyl-

blsuanlde of 0.1

II

lIole rathfno than 0.35

II

1101...

The larger

amount of tM. agent was dl.scovered to cau.e the death of the
animal. before they could b, uled 1ft the exped.ment 1.1: •• 11.

The

eau.e of death was probably a fatal hyposlyeaaia.
The result. in Table XVII indicate that this cOlBpound i8

-104.

TABLE XVI

or lR,zIQIlQl $lit cHltOlPl9PN11QE 2ft lHi. IN !ll]O
I"Q9BPORAl1Oft or LIUCINE-C1• INtO HlrAIIC PRQIIIN OF
I"ICT

I9IMt:L

MtS (LlnCS-MTES

Y§ml.

Injection

Rat

Number

1
1

2
2

3

3
4
4

C.P.M.

alva

saline 0.35 m Mol••

..
..
.

cb,lorprop_ide 0.35 m Mol••
.J

..
..

1527
1710
2256
2049

1443
1300
1110
1071

.1 OS•
• imilar: to the other two studied in that it. admln1.tratlOll

ia l1!I can re.ult 1n a decrea•• ln the abll1ty of the ant.a1a
11vel' to 11'lcorporate leuclne-C14 lnto pptein

iI.

ntn.

The.e experllRents lndicate that • lar,8 lnjectiOll of uy
of these as_ta can re.ult in a d.er.... of protein anaboll,_.
Thi. implie. that the direct effect of the c.pound

Oft

prot.in

.ynthe.i. is of a are.ter .asaitud. tban otber: effects .ueh ••
tba stlaulatlon of lnsu11n productlon by the paller....

It.eeraed

qult. likely that ... 11er 1ajectloas of the a.eats would r.ver ••
the .ff.cts .1lCI a nat

pr~.in

8IIaboll_ would ba noced.

aaeaftt

and 'l.cher (88) hpol:'tad . . 1.fter.... ln the lDeorporatloa of

leucine-C14 lnto protelD of rat liver .llc. it the donor ant.als
weI'. adad.DlsteC'ed to1but_lde (20 IlIIIOOa> for 4 • S day..

nn.

ber.... lD lDcorporatlOD by the tolbut_lde treated anwal.

was oODald.C'ad to b. a reault of an laor.... in unll. ..oretlOD f r . the

pea......

The next _perla_C. were de.lped to

verify thi. ob.el!'Y8tlOll anel extead 1t Co the othaC' oral hypo.1yoaa1o a.ent, pbenethylblSU8Dlde.

1a'Rt1'MD11

JP - Jl: IC'. . .21 IUMIE la 1tatl nl .t1 101\115'-

IWIa ... J.bIla

XiSlo

lannoYSl.1I .If. lr.nsl at:c14 .\W fttp!SJ.'

lat.J.p,
, ... le 11tter. . .te. were injected with 0.1 •••1. of tolbutamlele .ubcutaeou..ly for a period of tl.me.
were inj.cted wlth . . equal quantlty of ••11n..

Control udma1a
Thi. _ount
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TABL! XVII

KFECt or
VITIO

Ul,mCTION Of

lNCORPO~110N

or !9JY1AL M1.§

or

PHguHILI1GUAN1Pi

Number

1

1

Imt II

l.tPlCINI-9 14 IN10 HEP"TIg PROT,,]!

(LIUEI-H!\TIS

usmu.

lajeetion

Rat

ON

C.P.M.

given

aaline 0.1 m Mole.

..

2540
2504

2

It

2991

2

It

3096

3
3
4
4

PEBG 0.1 m Mol.s

.
..
.

1790
1745
1828

1865

-101(0.1 m mole) i8 equal to approx1mately 30

m&.~!nieh

corresponds

to 30 maJrat or 20 _&/100& since the weights of the animals
were very close to 150,.

Two 8xperiments were run, each using

3 control ani:llala and 3 tolbuta'l'ii-1e treated ones.
30. the animals

~~re

In '3:xper1ment

injeeteddaily for e. consecutive days and

sacrifieed on the mornios of the ninth day.

In

Exper~.nt

31,

the animals were injected daily for 4 consecutive days and

sacrificed the following mornina.

A separate homogenate was

prepared from the liver of each animal and the usual

incub~tion

performed.
Tb.e results in Table ::.'1111 indicate that no net effect is
found in this type of experiment.

the data demonstrate neither

an inhibition nor a stimulation of protein biosynthesis.

This

is in contrast to the preViously mentioned work. of Recant and
Fischer (88) who reported a stimulation of protein synthesis
(us1nS incorporation of 51yc1ne.014 into liver slice protein as
• criterion) under the same conditions.

In the present experi-

menta, it appears as though any stimulation of incorporation due

to an increase in in.ulin production ie Yery nearly balanced by
the inhibition of incorporation due to the tolbutamide its.lf.
The pre.ent dataare reasonably consistent and do not lend comfort to the theory tbat tolbutamide exert. an anabolic effect
¥be administered

1! .D.D due to an increased inSUlin production.

.108..

TABLE XVIII
KFI£&: OF Yf~tle lR:li£I'2!~
'" Vli!9

1!C9RfOMT101!

or IOL8U:wJ1Di

OF LlY)!lNlw C14 INtO

Qf! lUI

liEtAll)!

fi.2II'l!

Rat

Number
1

Injection

Experiment: 30

Givea

C.P.M.

e.p.M.

2022

7026

1983

7264

2586

122.45

2604

12397

Saline 0.1 m Mole.

.
..
.

1
2

2

Exper1ment: 31

3

ft

2904

114.50

3

»

2844

11723

2026

11450

1917

11407

3061

10380

.-

2970

10135

..-

2376

10067

2501

9934

4

Tolbutamide 0.1 m Mole.

4

5
S
6

6

..
tf

Experiment 30:

Rat. injected daily for 8 days

Experiment 31:

Rat. injected daily for 4 days

-109b2!r1.m!m~!! ~2

.. 33:

Eff.S'.at Repealed IDj"~'on!

bisuaaidl Rn 1b! In Vit[O Inco'poEatiOD

~

s1 E!bM.'b!l14
Leucine...C !D1!

Bill"$! Piq;IiD.
The procedure followed was identical to that uald in the
pr.oeding experimtnts exc.pt that • amall., doa. of this oral
hypoglycemic agent was used beoaus. of lts great.r toxicity.
The animala were injected daily for a period of 8 and 4 days
resp.ctively withelther 0.02 • mole. pbeftethylbiguanide or 0.02
III

mol•• sodium chloride.

Incubations were performed as usual

the day aft.r the final injection was Liven.

Th. data in Tabl. XIX dlmonstrat. that th.re i . no con.i ....
t.nt .ff.et upon the ia

Xilil

incorporation of leuctn._C14 into

h.patio protein by daily injection. of this amount of phenethyl...
biauanid..

This is similar to the ca••••en When tolbutamide . s

injected daily for a period of tta..

The.e results are signifi-

cant in tbat they show that neither o.f these a,ents caus. a net
stlmulatlOl'l of !\epat!.c protein synthesis under the condit.ions

studied.

This is in contrast to results seen followina the in-

jection of insulin (91). and may be indicative of a failure of
tho oral hypoalyc_ic asents to adequately control the prote1n

inbalanoe a.sociated with the diabetic state.

From this work,

it appears as though these compounds are inferior to insulin in

this re&ard becaus8 they fail to reproduce its stimulation of
protein synthesis.

... 110.

TABLE XIX
E:FFiCT OF REPEATED INJECTI9H§

qr

PHENEIHYL~tGUAIU.Di

QN THE 1ft VITRO INgORf2Mil0N Of blWSiUn;:.g14 INTO

fmPATIC PROTlt!

P

Rat

Injection
Given

Number

1

Saline 0.02 • Moles

bill.

Experiment 32

C.P.M.

Experiment 33

C.P.M.

96S

6110

1

It

916

5964

2

It

1328

9836

2

Q

1443

9837

3

n

1730

8003

3

It

1700

8438

4

PEIG 0.02 • Mole.

1595

7426

1540

7126

4

..

5

It

--

6224

.5

t1

2310

6224

2030

8671

1880

8746

6
6

..
II

Experiment 32:

Rata injected daily tor 8 days

Expert-ant 33:

Rata injected daily for 4 day.

~l

lDIl1mentl 34 -

l(f'S5

1l1ln l1x2

10 1'9;108

sf.

IolkYtgj.d.

sl t1.\.eroIQll\etl !!ll1 C!2 11 Sap !! .lnegrpor.S!
LtyIln~C14 ~to HIR!tic Protein.
Two aeta of l!tt.r~c.at cona18tin& of three aD~a18 eacb.

Jill !b~R!lat\ve i\~i.l"tx

wen .eel in . .ch expes:iaent.

Oae a.t of animal. wea injected

with 0.35 • molea of sallft. aad the other with

aft

equal quaatity

Atter 2\ hour•• the livers from each set of

of tolbut_ld..

aalmal. were pooled and two ••para•• hem",..at.a (trom aaU.!le.....ted aad tollNt_ide-treated ..ata) wer. pr.pared.
. . . . 8ftd "11 .ap fre .ach

t..

••pa...

~. ._at"!

The micro-

,,,eN 1.olated aad kept

Four ••ta of experlmental oODcU.tions we!:. employed la

thls expec1.aae1ltt

one s.t of lneubatlon f task. contaln.d both

.1eroa••• and cell-.ap , ... contl'ol an!.mal., a .eoOftd s.t

COIl-

tat.ned the . .11 up f l ' . cOIItrol aa1lDala and the aicroscm.•• frOll
tolbut_lde-injecrted on.a; a ChiX'd uNd cell sap frOID 'tolbuta-

aide-injected arti...al. but microsCIme. frem cOD'trol OD.S; and the

fourth ••t

. .plO,Yed

both micro._•• and c.ll sap from tolbuta-

aid.-treated animala.
'thina about Cbe

In thla

J.a :AD

lIaN1... it wa hoped to learn .om. .

8ite of actl. of tolbut_l•• 1n respect

to lta 1ab1blclon of hepatie protein biosynth.sis.

The re8ults

.f the.. _pttrimenta are auanarieed in Tab 1. XX.
The data 'emon.trat. an inhibition of incorporation of

leucine-C14 tnto hepatlc prote1n When the cell-•• p uaed le froa
the an1mal. injected with tolbut_icte. but no lab1bU:iOll when.

only the .1. .8 • •a

t ....

&rd.mala injected with tolbutamide an
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TABLE XX

EIFIOT. Or

IN

n VO

Ift,J:ttQrloR OF I2LIlJIAMIDE 2ft

IlLATIVE ABILITY 0' MlcaoSQKis AND gILL SAl
QQ!f9RAtl Llu9lRI_c14 lKIO §lPAIlg Plotili.

CELL SAP

SOURCE

KICItOSOMES
SOURCE

tHE

TO

lU-

COURTS PER MINUTE
EXP.34

EX'.

35 EXP. 36

Control Animals

Control Animals

3047

2447

1870

Tolbutamide Animal.

Control Animals

2383

2049

1457

Control Animals

Tolbutamide Antaals

3185

2556

1797

Tolbutamide Animals

Tolbutamide Animals

2559

2159

1425

Each datum represents the mean of three determinations

-113.ployed.

Further, the inhibition by the cell-.ap alone from

tolbutamide-injected animals is of the s . .e mapitude .s that
obtained when both cell sap and microsomes are obtained from
tolbutamide-treated animals.

It appears not to matter which

.et of animals the microsomes are deri.ved from, but an inhibition of protein synth.sis i.s always seen to occur if th.e cell
sap is derived fr_ the tolbutamide-treated animals, and no inhibi.tion i.s ever ••en when the cell sap com•• trem the control
animals.
At first alec.f these reaults.iaht appear to contradict
those found

.1n DIEo

where it was concluded that tolbutamide acta

at the microsamal level.

There is really no contradiction, b.-

cause the tolbutamide i8 not shown to be actina in the cell sap
bere, 1t i8 merely pr•••t in the cell .ap.

Evidently. when the

an:lmal 1. injected with tolbutamide, it realains dissolved in
the soluble portion

ot the cell and doe. not bind to any extent

with. the microsome..

Thus when one adds the cell.sap trOll an.

animal previously injected with tolbutamide, he i8 in .ffeet
addiftl a dilute solution of the compound.

ThiS, then, cause. an

inhibition of proteln synthesis s_ewhere at the mlos:oscma.l level
but the tolbutamide ltaelf does not bind to the m1croao.e. to
any extent.

On the other band, when Ofte adds microa.es frem.

tolbut.lde treated animala. he 1a 80t addln& anyapprec1able
amount of the compound and, 1f normal cell-a.p i • •ployed, the
i.ncorporation of leucine-C14 into protein is not depre••ed.

-114The•• experimertt. indioac. not only Chat tolbutamid. doe. not
bind to the Illerosom•• when

lnj~ed

a aD.

but al.o that it

does not oaus. any irrever.ib 1. change t.n the micro.... slBe.
they still retain their

no~l

capacity to incorporate leuctn..

Ct4 tnto hepatic prot.ln.

IXMrJaaS. ~Z - ~'I

1""'.1[ 1a liD '8"1.• .It ttMttiD'AItlrPMllr'. . . . I'LtI&YI ."&.11% .II. Ml. . . . . . 11.4 C,ll I!.a 12
'_OKlt, Wt1at::Si14 1111 iM'IItS bllfj,p·
'nel •• l,.
perfoc.ed

the . . . .ftC

of .. cr••

·.-owZ'· experi.aellt. w.re

u.lDa pbeDetb,rlbl..-nlde lal.ea. of tolbu. . .ide ••

the 01'.1 hypoSI,....i. aseat.

T'M result. prel.tecl la table XXI

are WS'7' similar to tho•• fOWld pnvloualy for tolbutaalcle.
the cell sap

If

t. olttaiDed frCllD an animal pnvlOU81)r 1njeocecl with

plumeth"lblpumid. t tun will be • d.cr•••• in ebe Ja DID
14
lncorporatiOl'l of leuolDe-C
lftto hepatic protein. Then is DO
eff.e. on the 1Deos-poratiOD of leuot.ae-C 14 lnto pC'Ot.ln wbeD only
the .10ro._e. are d.r1.ad Ire. a

anlaal.

pbeD.C~lbiJU&ftid. .laje.ted

The•• reeults an lntes.-preted •• beforel

the pben.etbyl-

blp&Dlde. Itke the toll.Ntamlde. is present ln the cell .ap la

l.lutlO1l and i. n.. .ppnoiably bound to the .10ros_.s.

Tbe

slal1ar behavlor of the two a_poundl 1. not U1lUIU&l 1ft tbls
tns ..aa•• ala_ both are water s.lulll. and .1allt b. expeC1:ed to
&CCNlRulate ill tbe solubl. ponlGl'l of the oell.

-11S ..

TABLE XXl

IfFiCt or 1ft V,yo IN J ikil21 Of PHiNiTHXLjliYhN1RE QI
Alii i&!i\tlU All'=:ItX Ql MlCi2t9JiS Ala Qilwlc sal to
INy01PQM11 LI~ID_C14 IU9 HlfAti c pmill •
•
CELL SAP

SOURCE

MICJ.OSOMES
SOURCE

cO'JRTS PEa Mll!ruT!
EXPEltDtENT 37
I

I

I

IXPDlMENT 38

, ,

C_te...1 6nlmaia

Ccmterel Aral... la

2528

2416

PDQ Anlmal.

Cont:l'Ol A.1Ml.

1810

1489

Cemcni Aai.Dlala

PDO Aa1mal.

2S63

2218

PIIG Anlaala

rEBa Aa1m&l.

1790

1372

U

I

IV. ~::;UMMARY AND COliCLUSlONS

Althouifth a lar,. amount of work has been reported in the
literature on the effeets of insulin on protein biosynthesis,

very little attention has been paid to the Qorr$spoudlng effects
of the oral hypoSlycfim11c a,gents.

Since th.ese COl'4pounda are

widely used '.n thtil control of eertnin types of diabetes, it was

considered worthwtd.le to investigate their effect
synthesis for two r86eOftS:

Oft

protein

first, to ovaluate th.eir effLcacy 1n

the control of the ent1re diabetic statf:', and second. co obtain
some inSight. if potulihie, into their mechani.sll'l of action.

Two

particular compOtmds ",ere studied in deta.il; tolbutamide, a8 a
representatlve of the arylsulfonylure. compounds. and 'l,)henethylbis,U4nide, as a representatiw of the guanidine derivatives_
Thes. two classes of compounds haft been shown to differ in &any

respeets. a ftnding which il usually

different mechanism. of 4cUiOft.

in~erpreted

.s indicating

'the arylsulfonylureas reduce the

fa..tins blood sUiar level of bt.ct and partially pancreatectomized or mildly alloxan diabetie anima.ls, but they do not do 10
after: total pancreatectomy in d08S. rabbits. rat., or man, nor

in animals made severely diabetic with alloxan (77) (110).

These

observations have been interpreted as indiaating that tolbutamide

acts by sti.aulatln& the paner_. toproduee more lnsuU.n.

The

mode of action of pbenethylbiauanl.de differs markedly from that
of the arylsulfonylureas

compound 1.8

aft

a8

evidenCed by the feeta that tMs

effective ltypoSlyc_ic ageat in pancreateotcalzed

-117an.imals (82), in severe alloxan diabetes (102). aDd ln patlents
with juvenile or inauU.n deficient type. of diabetes (87).

Evidently, phenethylbiguanide does not require that functional
pancreatic tissue be present.

This fact excludes the possibility

that it acts by st1mulatingthe beta cells to produce more in-

sulin as bas be. proposed for tolbutamide.
It bas been oba.rved. however, tbat both of thes. compounds,
wh_ added

Ja BIEI, have a similar, inhibitory effect on

the

ineot."poration of leucine-alit lnto hapatie protein when used with
the mict."os<'.IIles and cell sap isolated from normal rat l1ftr.
Thill inhibition. Whioh baa also been ob.erved with chlorporpamide,
is llnear over a conc8Dtrat1on r88le of 0 .. 10 lIM.

Simllar

con.dtration. of sodium chloride have shown that this 1Dhibltion
cartftotbe .lIcribed simply to an lnC1:ea.e 1n 10nic strength or

an incre.se 1n the aonGefttratlon of sod1UDl ion...

TM. Ja

n~l'g

.ffect is important 1ft that it "pr•• ants a direct effect of the
compounds. independent of their pos.ible .ffeots on insulin production or other control aeohani...

Wb._ the experiments

were

repttated using the eell-s.p and mlcrosomes from allOX4ft-dlabetio
rata t the ent1"8 level of incorporation was so low that it waa
diffioult to detemine whetber a aigrd.flaMt inhibiti. . occurred.

1 t was certain, however t that In nO ca.e did the campounds stimulate protein bioaynthe.is as ali.&bt be deatH<! in a compound used
to treat diabetes mellitus.
A mea8u,,_ant o.f the .ff.cte of the ccapounda on both

.oluble and .1fto. . .l bound pncet.ashGwed that 1ftoorpor:atiOD

was depreaHd equally i.ft both fr:acrclona. 1ad1oatlna tbat both
the tOlbutamide ad phelet'bJ'l.,ipaa1d. in<luead 1nb1bltlon
000Uft'ed before thepnc.la

they dld DOC .ffect the

w.

~.l. . . .

n l...ect frGal the I1.bo. . . i •••

atep 1n tbe blo..,atbetlc paCbway.

Othn' u.ped.lDat.. ln which the leuet.a. .c 14

pn.1Douba.loa vt..h the cell

"p,

wa_

oharsed by

5.ftc11eat. tbat tbe t.DhlbitlOft

la both ••••• ocrfl'UZ1:ed afe_ tbe ' . . . .cl-. of .be _lao acyl-

••IM . .,la.

.'D.

In other WOI'd •• 'boCh t.1IN.-s.de aa4 pheeebyl.

blauaald., added

Ja

lahlblt tbe lD~Ct._ of l_ala••

0 14 lato hepa'le p~ot.ll'l ......... at the 1....1 of lbe .1.. . . . . . .
Tbl. 1. DO' to sa,.

~t

tbey h~

a.. I.. pnci.ely lbe . . . .

I.

........ for: ltd.. i . a ....,. a_pla .eque. . of l'8&eCt.oaa.
eOllp«m4 alp' . .us. d1saa,peaatt.oa of

other:

alp- aff_

aDd tbe t.,late.

the annen1_

One

riMa. . . vht.l. Che

"etweea tbe aatao AflYl•• -RNA's

11......1.... 'tHMrh . . ., . an ....

appl"OJd.aa'e1,.. ebe . . . polDt 1ft t.ahl.bielaa the

'0 aft at

.Ira YJ.In biosyn-

theai. of hepalic proeeln.
A . . . .41

.en.••

of exped.Mllt• • • . .wi . . . 1a ¥hleh the

a..,.e. . . . . lnjeoted lnto laCaoc ard..al..
~.....

The l1fta

w" ehell

aft_ a period of tllD. aa4 lbe ald,U.cy of culr: . l. . .

•••• CO laeorponc.

1~a14

lato p"'eln

wa.

_.pand with

that of .1. . . . . . ded.ve4 f..- tM 11'N1:8 of CIOD....1 anlmal.

lDjecn:ed wltll saU.n..

Wb.a lln.....t ••

wen • •1oy*,. lc wa.

appaNltc tbat a .I.nale lIlj••Cl_ of colbut_ide (0.3S .ill1.

moles) or of

decreased

phene~hylblguanide

abil1~y

of the liver

C14 into protein in yitIo.

(0.10 mill! moles) resulted in a

micros~••

to incorporate leucine-

Th••• results indicated that the

inhibitory effect of the agent it.elf was greater than any stim.

ulation it mi&"1.t produce by a secondary effect (8$. inereased
production of insulin).
When animals were injected. daily for a period of time (lor
2 week.) with the agents (tolbutamide lnjeetion 0.1 m mole per
day; phenethyl"igu4l\ide injection 0.02 m mole per day). there
was no appreciable effect on the ."111ty of their livers to
14
incorporate leueine-C
into protein in !iSEo aa compared with
control ard.mAlls giv.n 1Djections of .altn..

It might be .sfJUDted

that under these oonditions tolbutamide would enhance leucine
lncorporatlae into protein by virtue of increased insulin preduction. but such was not: found to be the ease.

!v1dently the

inblbitory etfeet of the tolbutamide was sufficient to otfset
the ettMulatioo produced by increased insulin production.

A senes of cross-over exptriments was perfomed 1a which

the microsome. from laline-injected animals were incubated with
eall sap frem tolbueamide injected animala. etc.

thea. r.sults

showed an 1nhlbt.tion by st.tber agent wben the cell sap from an
animal treaeed vien the agent was used I!U1d no lnh1bleion when
only the microsomes trom. treated animals were employed.

The.e

results indieate that been tolbutamide and phenethylbiguanlde

are located in the soluble call sap and are not bound apprecd.ably

-120.

to the microsomel.

When the eell sap from an animal whieb was

previously injected with an oral hypoglycemie &,ent is added to

the 1n !&t[O system. it is essentially the same a8 adding a
dilute solution of the alent and an inhibition of incorporation
is observed.

The results of thi. investi&ation. then. demonstrate a num-

ber of similariti•• between the effeets of tolbutamide and pheDethylbiguanlde on protein biosynthesis.

Both oompounds inhibit

the incorporation of leucine.C14 into liver protein when added

in

n'a-

ma~nitud.

In both ea •• s the dear•• of inhibition is of the sam.
and i . directly proportional to the concentration of

agent added.

this inhibition occur. somewhere at the microsomal

site for both asents. indieatin, Similar, thoua,h not lUtc€,ssarlly
the same. meehani._ of action.

Purther, an acute larse

JJa .x1:r.2

injection of either compOWld results in an impaired ability of
the animal's liver to incorporate leueine..C14 into prot.in in

nfEa.

This

An %l.x2 lmpab:ment is found in the cell sap of the

injected animal probably due to the solubility of both compounds
in aqueous solution.

Neither tolbutamide nor phenethy1blauanlde

appear. to bind to the microsam.s to any extent.

Thes. similarities are unusual in that the two agents
pos.... different mecnanisms of action in regard to their effects
on carbohydrate metaboU.am.

This only serves to emphaaize the

fact that their effect on protein metabolism 18 not a secondary
phenaa.non dependent upon the effect on carbohydrat•••

-121The physioloslcal and clinical interpretations of these
results are not conclusive. but illdieate tz.."s"'e thee. agent. do
not control the imbalance in protein metabali.8m assoeiated With
diabetes as well as insulin does.

~~enever

an effeet of insulin

em proteill metabolism has been ob.erved it has been one of Increasing protein biosynthesis
process.

rathe~

than of illhibiting the

That the oral hypoglycemic agellta can inhibit protein

biosynthesis

S&tlmS

clear; whether: this lnhibition oeeurs to any

extent in the adult dlabetic on a daily maint'enance dose of tolbutamide or

phenethylbi~uanid.

investigation.

falls t4ithin the realm of elinieal

There are only a t4'i scattered elinieal report's

in the literature on this subject at the present time.

Mutln!

(80) noted that there was no ch4ns,e in serum protein comp"sltion

of 101 diabetic patients after successful lone term tr••~.nt
with tolbutamide.

Dei~eutter

(23) demonstrated that following the

administration of tolbutamide to normGl subjects. there was a
decrease in lerum amino acids eomparable to that tollowin! the
administration of insulin.
On the

other hand. Green_er!, and coworkers (34), approaching

the problem of the efficaey of the oral hypoglycemic agenta from
a clinical point of view, have arrived at conclusions substant-

ially in agreement with those presented here.

They observed a

alsnificant: ris8 in beta-lipoprotein levels in patients sYitchad
from insulin to tolbutamide therapy.

Thus it: appears that there

are at lea.st two areas in the diabetic condi1:ion. protein and

-12211pol'!.'Otetn "'8tabol1a., when the oral
1:0 _en ~:'d"mtJm ftOl'ttrol.

"""1"01\ on the .ffecta

bypo~lyeemtc

asent. fall

This tndtee.t•• a need tor: further

of the 01'.1 bypo@;lyeemle as;enta

Oft

ot:lwl"

.epee1:. of tll.bette m8tabolt., web •• U.pld and Duelei.e acid
•••aboll.lIII.
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TABLE XXII

or

STRUCTURES

ORAL HYPOOLYCEMI C AGENTS

Tolbutamide

c=c
01 -

C/

~

"

C-

~

C-C

S02NHCONH(C~ )2CH,

Chlorpropamide

C=c
/
C~

"

,C -(C~)2 NH~HnN~
C-C

58 ""

Pbenethylbisuanlde

... 140.

TABLE XXIII
EPFIc;..91

or

WA§H1ftGS

I

All the wa.hinss of on. protein fraction were saved.

A

1.0 ml. aliquot of .ach washiDI was plated and counted.

WASHING

C.P.M.

Volume of Wash
(ml.)

27,500

6.2

4,700

S.O

EtbAllol 1

346

S.O

EthAnol 2

149

S.O

Ethanol 3

29

S.O

Acetone 1

17

S.O

Acetone 2

14

S.O

Acetone 3

18

S.O

tJ

Supematant

TCA

After the third ethanol wash, • bacqround
obtained.

COUftt:

is

Tbis indicat.s that the va.hinSs employed

were sufficient to remove nonincorporated radioaotivity.
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TABLE XXIV
m1CACX OF WASHlNGS

II

The flnal aeeton. wash fram each of 11 flasks was saved.
1.0 mI. of this was plated out and counted to check the
efficiency of the vashin•••

SAMPLE NO.

C.P.K.

1

1.~

2

13

3

16

4

13

S

12

6

11

1

11

8

14

9

14

10

12

11

13
•

c....

The fact that a backr;round COUDt is obt.ined in all
atte.ts to 1':1'-,« l!9t'flclency of the washins pro-

cedure 1n reMovin& nonlncorporated radio.ctivity.

TABLE XXV

DATA ON ALLOXANllED RATS
Rat 4/25 4/26/66 4/27/66 4/27/66 4/28/66 4/28/66 4/28/66 4/28/66
vat. uruulry UJ:inary urlnary wit. urinary urinary b loGe!
glucos. 81uco•• ketGft..
81UOO •• ketone. gluco••

Ro.

1

157

2

145

3

IS9

4

150

S

145

6

146

7

152

8

ISO

9

IS4

10

IS4

11

159

12

152

-

-

+
+

-

trace

-

+

-

+

-

-

+
+
+
+
+

+

+

-

trace
-

-..

trace

trace

-

lIS

+

trace

1160

108

+

+-

1400

113

+

1212

116

+

-

+

1860

119

+

+

2480

114

+

trace

736

118

+

trace

1472

Dead

x

x

x

119

+

131

+

132

+

119

+

-

-

Animals war. injected 'tilth 20 ma/K,. alloxan at noon

on 4/26/66

1128
952

1152
2456

TABLE XXVI

9Q1POSITIO! 9l

UI').ABELED AMltlOACID SOLUtION

AMINO ACID

H.W.

q/SOO ml.

Dt - Ala

89.1

25.4

L ... Ar:g.

~no. 7

30.2

DL ... Asp

133.1

38.0

L ... CyS

115.6

2S.1

L ... CySS

240.3

34.4

L ... Glu

147.0

21.0

15.1

10.7

L ... His

209.6

30.0

DL ... 11eu

131.2

37.6

L ... Ly.

182.7

26.1

DL ... Met

149.2

42.6

DL ... Phe

165.2

47.2

L ... Pro

115.1

16.5

DL ... Sar:

10S.1

30.0

DL ... Tbr

119.1

34.0

L ... Try

204.2

29.2

L ... Tyr

181.2

2S.9

DL ... Val

117.1

33.4

131.1

18.7

Gly

L ... Pro ... OR

The .olution • • so d •• i8lled that there would be .043 u mol••
of each L-amino acid per 0.3 ml.1af .olution. Thi. amount. to
10 tlrae. the _ount of leueine-C
added per f l •• k.

-144-

Iff.ot 1it lbI C_ _ tr.tilP s! Pb• •tllYA!!,·
1Ulp14. . . .IIa IDlOQ9I',,1 111.t11·!"'f..II-gI4 J.atI §eRlt's lus,y!
.If. 1,.,1
ixPH1aDS

~3A:

1ft,.

Thi. experiment was pact.ned .fter _perlalDt 13 (P. 74)
and va. de.iped to wrif)' ,he .ffeet of t _
of pbeftethylbt.guanid. on tbe

hepatic prot.lll.

ill nero

addition

lDeo~oration of leuoiDe-Cl4 into

Mlc........ and eell ••p fraa nomal anlul.

wen incubatecl with vaX")'llll _CNDt. of phela.thylbt.panld••
'lbe hault. . . . . lD 1'1...- XII1 support tboa. o.tained

..... ll.r 1ft Ft.au" Xl (P. 75).

It 1 . . . . . tbat pbeMthylbt.panld.

iDhlblt. the lA. .,..atiOll of leu.et.at-CI4 lDto _patio prot.in
wha aclded

.Ia n5D. nt.••~daeDt

verifl•• the ob........tion

,bat tbe d'ane of t.nhl.bitlO1l 1. clinocl" p ...oportional t. the

_ouat of aaent .deled oYe.. the ran.. of 0 • 10 11M.
haVior of pb.eD.tbylblauanld. 111 thi.

."et. 1.

Thu. the be-

wry .imilar to

that of tolbut.ld. and ohloJ:p...opaaid. (a. . . . . 1D rlp.... Xl).
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P. E. B.G. Ii- MOLES/ML.

Figure XlII
The Effect of the

111

ntES! Addition of Phtmethylbiguanide on

the Incorporation of Leucine.C 14 into the Protein of Llver
Micro.ome. from Normal Rats. (Confirmatory Experiment).

The dissertation submitted by Lawrence R. O.Chatelet haa
been read and approved by five members of the faculty of the
Stritch School of Medicine, l.oyola University.
The final copi •• have been examined by the director of
the di •• ertation and the signature which appear. below verifi.. the fact that any necessary chanS.. have baen incorporated and that the di •• ertation is now given final approval with
ref erence to content t form and mechanica 1 accuracy.
The dis.ertation is therefore accepted in partial fulfill-

ment of the requirements for the dear•• of Doctor of Philosophy.

Oat.

Signature of Advisor

